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Abstract 
Purpose: Advances in the field of radiation oncology have dramatically improved our ability to 
effectively target cancer cells. Techniques such as three-dimensional conformal radiotherapy, 
stereotactic radiotherapy, intensity modulated radiotherapy and volumetric modulated arc 
therapy allow the dose to be effectively shaped to maximize radiation delivered to the target 
while minimizing the dose to the surrounding tissue. It is vital to ensure a precise dose is 
delivered to the target volume and most of the above techniques mandate pre-treatment 
verification of planned fluences. This could be achieved by several dosimeters available in 
radiotherapy such as ionization chamber, diode, TLD, 2D Array, etc. Specifically, stereotactic 
ablative radiotherapy (SABR) uses small fields which mandate the use of miniaturized detectors 
for pre-treatment verification. Alanine and nanoDot are new classes of dosimeters that need 
to be characterized for pre-treatment verification. The aim of this project was to evaluate 
multiple detectors for SABR patient verification and develop a spherical array detector for 
verifying the dose delivered to cancer patients undergoing stereotactic 
radiotherapy/radiosurgery or conventional radiotherapy involving non-coplanar beams. 
Methods: Prior to SABR pre-treatment verification, all detectors were assessed for dose 
linearity, energy, and directional and dose rate dependence. The Bruker EleXsys E500 EPR 
spectrometer of 9.5MHz was used to read the alanine pellet dosimeters signals; Harshaw QS 
5500 automatic TLD reader was used for reading the TLDs and Dose 1 electrometer was used 
to read the charge response of microDiamond (PTW60019). Microstar Reader from Landauer 
Inc. was utilized to study the signal of the irradiated nanoDot OSL dosimeters while PC 
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Electrometer from SunNuclear was used to collect the signal response of IN5626-diode 
distributed on the surface of the designed phantom. All irradiations were performed using a 
Clinac 21iX at 6 MV x-ray beam. A 3-D novel spherical phantom was designed using Via card 
software. In total, 120 holes were created on the surface of the phantom that allows the 
insertion of diodes (IN5626). The phantom was printed using CreatBot 3-D printing machine. 
Also to check the suitability of the evaluated detectors, 3-D phantoms were designed for each 
detector and were placed separately inside an indigenous Rod phantom made of Perspex to 
perform SABR pre-treatment patient verification. The statistical analysis, linear and curve fitting 
was done using OriginPro® 2018 (Origin Lab® Corporation). 
Results: The relationship between dose measured using Alanine, TLD100H, nanoDot and 
microDiamond dosimeters, as well as a diode (IN5626), followed a linear fit of R2 = 0.9993, R2 = 
0.9999, R2 = 1, R2 = 0.9999) and no significant difference between dose rate and energy was 
observed for the detectors.  For all three sites (sternum, spine and scapula), the average 
measured and planned dose was recorded for alanine (18.29 ± 0.91 %  and 18.57 ± 1.12 %)Gy ,  
microDiamond (17.76 ± 0.65 % and 17.68 ± 0.63)Gy, nanoDot(18.29 ± 0.85 % and 18.64 ± 
1.31 %)Gy and TLD100H (18.28 ± 0.70 % and 18.29 ± 0.85 %)Gy respectively. The differences 
between the measured and the Treatment Planning System ( TPS) computed dose was within 
2% for Alanine, nanoDot, and microDiamond, and 3% with TLD100H respectively. In terms of 
ArcCheck and film dosimetry, the gamma criteria at 3%, 3 mm were found to correlate well with 
our non-SABR spine routine patient-specific QA results. Significant reduction in QA time on 
using ArcCheck for SABR QA in pre-treatment verifications. The results obtained from the novel 
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spherical phantom designed shows excellent dose distribution on the surface of the sphere 
using python code compared well with the treatment planning system (TPS) dose distribution 
on the surface. 
Conclusion: This study indicates that the evaluated detectors are consistent and agree well 
between the measured and the planned doses. Particularly, alanine and nanoDot indicates 
excellent dosimeter quality and therefore are confirmed as valuable dosimeters for SABR pre-
treatment verification. ArcCheck results indicate that it could replace film dosimetry for all sites 
except SABR spine. A prototype spherical array detector has been designed and the diode is 
characterized by linearity, field size, dose rate, energy and angular dependence. A GUI software 
has been designed to read the Dicom RT plan and dose from the treatment planning system 
and the extracted dose correlated to the dose measured by the diodes. 
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Chapter 1 
 
General Introduction 
 
1.1 General Introduction 
The word Stereotactic means the three-dimensional (3-D) localisation of a 
precise point in space by a distinctive set of coordinates that relate to a fixed, external 
reference frame. Such a frame represents resonating probes that have been carried 
either as conductors or biopsy pointers to precise locations within either an animal or 
human brain, created following analysis of plane and orthogonal x-ray films of the 
subject in the frame (Mayles et al., 2007). Stereotactic radiosurgery is therefore a 
highly precise form of radiation therapy primarily developed to treat brain tumours 
and functional abnormalities.  
Stereotactic radiosurgery was first used in 1951 with 200 – 300kVp x-rays 
(Leksell, 1951, Leksell, 1957) and later a specially designed unit with 179 focused 
cobalt beams (Leksell, 1968). Leksell’s cobalt beam unit evolved into a modern 
commercially available gamma ray unit incorporating 201 focused beams obtained 
from  cobalt sources, each with a nominal activity of 1.1 x 1012Bq (30Ci). This 
development allows the focal point to be placed stereotactically, with a dose rate of 
approximately 200cGy/min. While the dose fall-off outside the target volume is quite 
rapid for the gamma unit, the unit has several drawbacks, most notably a very 
restricted purpose and high capital cost,  in addition to costly and complicated source 
changes which are typically required every five years. 
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Stereotactic radiosurgery with heavy charged particle beams commenced in 
the late 1950s in Uppsala (Larsson et al., 1958), then Berkeley (Lawrence et al, 1962) 
and in Boston (Kjellberg et al, 1983) with proton beams from cyclotrons, and recently 
progressed to helium ion beams obtained from a 230-MeV synchrocyclotron. The 
technique is based on advantageous Bragg peak dose distributions from energetic 
heavily charged particles, given with multiple field irradiations (up to 12) resulting in 
a sharp dose fall-off outside the target volume. Its main disadvantage, however, is its 
dependence on high-energy cyclotrons or synchrocyclotrons as the source of 
radiation, making it very expensive, and therefore its use is quite uncommon.  
These techniques, the one using focused cobalt beams and the other using 
heavy charged particles, are thus theoretically quite well suited for radiosurgery and 
have proven their effectiveness on several thousand patients (Pike et al., 1987). 
However because of the high capital and operating costs, they are not widely used.  
An individual institution, which, even with a large catchment area, can at best expect 
to treat only several dozen patients per year, will have difficulty justifying the 
installation of this type of equipment.  
Less expensive alternatives to these two proven radiosurgical techniques are 
therefore desirable, and were developed during the last decade in several 
radiotherapy centres. These new techniques use isocentrically mounted linear 
accelerators (LINACs) as the source of radiation, and stereotactic frames for target 
localization, treatment setup, and patient immobilization. The linac-based 
stereotactic radiosurgery uses the rotational capability of these isocentrically 
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mounted linacs to concentrate the dose at the target, with a sharp fall-off in dose 
outside the target volume. In contrast to gamma units and cyclotrons, isocentric linear 
accelerators producing x- rays are readily available in all major medical centres, and 
may be used for radiosurgery with only minor modifications or additions. The 
requirements for spatial and numerical accuracy in radiosurgical dose delivery are 
relatively easily met by all manufacturers of linacs, as they do, even for standard 
radiotherapy, meet very stringent specifications on accuracy of isocenter (usually 
within 2mm ), couch rotation  (usually within 2 mm), and dose delivery (within ± 2% ) 
(Podgorsak, 2005). 
 
1.2 Current Technology in radiotherapy  
Recent advances in stereotactic radiotherapy have become possible through 
technological changes in conventional accelerators, leading to advanced dosimetric 
verification and stability as well as mechanical accuracy. Simulataneously, this 
development has brought about an increase in availability in the clinical standard for 
both mini and micro-multileaf collimators (MLCs) on conventional accelerators such 
as: BrainLAB,   BrainLAB AG,  Multileaf collimator, etc, as well as the institution of 
treatment units specially designed for stereotaxy (Gamma knife, Elekta instrument 
AB, Cyber knife, etc) or intensity modulated treatments (Tomotherapy Hi-Art, 
Tomotherapy Inc. Madison, WI, USA) (Alfonso et  al, 2008).  
These recent developments in radiotherapy delivery techniques have 
extensively increased the use of small fields for stereotaxy,  further to larger uniform 
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or non-uniform fields which are composed of small fields. This is the case for all 
treatment beam types, together with high-energetic photon beams, electron 
beams, proton beams, and light-ion beams. A small field is defined as a subject with 
a length smaller than the lateral array of charged particles. Nonstandard fields are 
either made up of small fields, or each time a non-equilibrium conditions occur; this 
takes place, for instance when the size of the penumbrae is similar to the size of the 
field (Das et al, 2008).  
 
 1.3 Pre-Treatment Planning and Verification 
Modern developments in external beam radiotherapy machines enable the 
precise delivery of high doses of radiation to the target volume, and therefore pre-
treatment verification of delivered dose is critical to ensure the planned dose is 
delivered to the target volume (Ravichandran et al., 2011), and prevent serious 
errors that may emerge from patient localization to treatment work flow.  Pre-
treatment verification of dosimetric parameters is routinely employed in 
radiotherapy for treatment modalities that involve complex fields, such as intensity 
modulated radiotherapy. It is usually performed as either a single point dose 
measurement or at different locations (planar dose) in the treatment fields. An array 
of detectors is typically employed for pre-treatment verification in order to measure 
the dose in the required plane. Several types of dosimeters are currently available 
for dose measurement in radiotherapy; these include ion chambers, metal-oxide-
semiconductor field-effect transistor (MOSFETs), diodes, thermoluminescent 
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dosimeters (TLDs), scintillation detectors, films, glass dosimeters, and optically 
stimulated luminescence OSLs dosimeters (Kumar et al., 2007; Prabhakar et al., 
2007; Yang et al., 2012; Al-Mohammed et al., 2010; Archambault et al., 2010; Shi et 
al., 2006; Rah et al., 2012 and Mrcela et al., 2011). These dosimeters each have their 
own advantages and disadvantages for different radiotherapy measurements. 
Recent studies clearly indicate the growing role of stereotactic 
radiotherapy/radiosurgery for intracranial and extracranial target volumes (Liu et 
al., 2013; Tozzi et al., 2013 and Chang et al., 2013). High dose radiation is delivered 
over a short period of time with stereotactic radiotherapy/radiosurgery, which 
requires stringent quality assurance in patient setup and dose delivery. To reduce 
the dose to healthy tissues, non-coplanar arcs are used with this treatment 
approach and stereotactic localization is performed prior to the treatment, when 
the planned computed tomography images are taken, in order to precisely locate 
the tumour. This precise localization and accuracy in dose delivery is very important, 
since the complete treatment dose is delivered at once using very steep dose 
gradients in order to spare the surrounding healthy tissues.  
The introduction of flattening filter-free beams for stereotactic radiotherapy 
has shown significant improvement in treatment time for dose delivery (Mancosu 
et al., 2012).  Measurement of spatial dose distribution is very important in this area, 
as the beam profile is not uniform. Dose verification is typically performed by point 
dose measurement or by using a 2D array of detectors.  The benefit of using an array 
for measuring the spatial dose distribution was highlighted by Erti et al. (1996).  
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However, the dose is not measured at treatment-specific gantry and couch angles, 
which results in uncertainty in dose measurement for non-coplanar beams. A pin-
point ion chamber/detector is commonly used for measuring the point dose 
(absolute dose), while films are used to establish the relative dosimetry. These films 
need to be placed at different planes in order to determine the relative dose for all 
the non-coplanar treatment fields.  This procedure is cumbersome and requires 
significant time to fully verify the dose.  
Hence, in this project we propose a spherical array of detectors to perform 
dose measurement for non-coplanar beams. The advantage of this approach is the 
measurement of dose across the entire surface of the spherical detector. 
 
1.4 Overall aims:  
To evaluate multiple detectors for SABR patient verification and develop a 
spherical array detector for verifying the dose delivered to cancer patients 
undergoing stereotactic radiotherapy/radiosurgery or conventional radiotherapy 
involving non-coplanar beams. 
 
1.5 Hypothesis 
Existing patient specific quality assurance procedures for stereotactic 
treatment fields employing non-coplanar fields are cumbersome and the phantom 
geometries are not suitable for measuring doses for non-coplanar beams. The use 
of the proposed proof of concept and novel detector development would eliminate 
most of the problems encountered in measuring doses for non-coplanar beams.  
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1.6 Objectives of the project 
 This research comprises the following specific objectives: 
i. Demonstration of the detector design using different dosimeters that include 
TLDs, alanine, ionization chamber, nanodot dosimeters and diodes.  
ii. Evaluation of mulitple detectors for patient specific quality assurance in 
stereotactic radiosurgery / radiotherapy procedures. 
iii. Development of a novel detector for absolute and relative dose 
measurments. 
 
1.7 Outcomes and significance:  
Quality assurance in radiotherapy is important as it ensures that the intended 
dose is being delivered accurately; many of the most serious clinical problems have 
been linked to a lack of QA. Pre-treatment verification of dose delivered to 
radiotherapy patients ensures the intended treatment goal is achieved. The 
spherical phantom will provide vital information on the spatial dose distribution of 
non-coplanar treatment beams in radiotherapy and ensure accurate radiotherapy 
treatment is delivered to patients undergoing stereotactic radiotherapy. 
 
The novel detector array: 
 Provides entrance dose and isocentric dose for each non-coplanar beam 
 Allows measurement of beam profile for real treatment conditions that uses the 
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same gantry, collimator and couch angles. 
 Provides pre-treatment QA 
 Allows for routine calibration of stereotactic or non-coplanar beams 
 Has wide applicability in radiotherapy and can be used for measuring dose in linac, 
cyber-knife, gamma-knife, and true beams.  
 
1.8 Thesis outline 
Chapter one consist of general introduction, aim and objectives, hypothesis 
and outcomes of the work. Chapter two givesa  brief discussion on the study 
background and related literature, the third chapter details methods and materials 
of the study. Chapter four details the design of the novel spherical phantom and 
software development while chapter five presents the results of the research work. 
Chapter six is the general discussion of the work. The seventh chapter concludes 
with useful recommendations for further study and highlights of thesis limitations. 
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Chapter 2 
 
Review of Related Literature 
 
 
2.0 Radiations Dosimetry basics 
2.1 X-ray Production 
X-rays are produced when highly energetic electrons interact with matter, 
converting some of their kinetic energy into electromagnetic radiation. A device that 
produces x-rays in the diagnostic energy range typically contains an electron source, 
an evacuated path for electron acceleration, a target electrode, and an external 
power source to provide a high voltage (potential difference) to accelerate the 
electrons. Specifically, the x-ray tube insert contains the electron source and target 
within an evacuated glass or metal envelope; the tube housing provides protective 
radiation shielding and cools the x-ray beam; and filters at the tube port shape the x-
ray field incident on the patient. The generator also permits control of the x-ray beam 
characteristics through the selection of voltage, current, and exposure time. These 
components work in concert to create a beam of x-ray photons of well-defined 
intensity, penetrability, and spatial distribution. In this section, the x-ray creation 
process, and characteristics of the x-ray beam are briefly discussed. 
 
2.2 Radiation Therapy Physics  
Electromagnetic radiations such as gamma rays and x-rays interact with the 
fields of the atom of the material which they pass into, and result in the production 
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of secondary particles of high energies which bring about an ionization event in the 
material. The interaction of gamma or x-ray photons with matter can be explained 
by three independent effects: photoelectric effect, Compton scattering and pair 
production. 
 
2.2.1 Photoelectric Effect 
This is a process whereby a gamma-ray photon transfer all of its energy ℎ𝑓0 
to an electron and disappears. The effect occurs only with a bound electron where 
the electron and the atom can conserve momentum. The photoelectron is ejected 
with energy as in equation 2.1 
0. hfE ep        (2.1) 
 where ∅ is the binding energy of the electron. 
The vacancy created is promptly filled by an electron from the outer shell 
leading to emission of characteristic x-rays (Fig. 2.1). This may in turn transfer its 
energy to knock off other electrons called Auger electrons. 
 
Fig. 2.1: An ejected electron by an electromagnetic photon showing charactersitc  
 radiation and ejected electron when a photon is incident on the atom. 
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The probability of the photoelectric effect occurring is approximately 
proportional to the fourth power of the atomic number of the absorbing material and 
inversely proportional to the third power of the gamma ray energy. This is why high 
z atomic materials such as lead are used to shield gamma radiation from external 
sources. This can be expressed as in equation 2.2: 
34
.  zep         (2.2) 
Where 
ep.  = phtoelectric effect probability, z the atomic number 
and 3  = the gamma ray energy 
 
2.2.2 The Compton Effect 
This is an elastic scattering of photons by a free electron. The incident photon 
interacts with and transfers part of its energy to a loosely bound electron in the 
absorbing medium. The electron recoils at an angle 𝜃 with respect to the original 
direction of the incident photon (Fig. 2.2). The photon itself is scattered with 
reduced energy ℎ𝑣 compared to that of the incident photon energy ℎ𝑣′ as in 
equation 2.3: 
 
 
)cos1(1
'
2


mc
hv
hv
hv       (2.3) 
 where m is the rest interaction and Ec is the maximum energy.  
Both energy and momentum are conserved. The energy of the scattered 
electron covers a continuous range up to a maximum energy Ec corresponding to a 
scattering angle of 1800 (equation 2.4). 
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Fig. 2.2: The elastic collision of an incident photons on an electron. 
   
        (2.4) 
 
The probability of Compton scattering per atom of the absorber depends on 
the number of electrons available as scattering targets and therefore increases 
linearly with Z  expressed mathematically in equation 2.5: 
 EZc         (2.5) 
 
 
2.2.3 Pair Production 
When a gamma photon with sufficient energy greater than 1.02 Mev is 
absorbed completely, a positron and an electron pair are produced whose total 
energy is equal to the energy of the initial photon  as in equation 2.6: 
 )()( 220 CmTCmThf epee      (2.6) 
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where Te and Tp are the kinetic energies of the electron and positron respectively 
and 2mec2 is the partial energy of the photon converted to mass of electron and 
positron. 
According to the excitation of the absorption crystal, Te and Tp  then 
annihilates to produce two photons with energy 0.511 MeV each in approximately 
1800 to conserve momentum (Fig. 2.3). Therefore the probabililty of pair production 
occurrence can be expressed as in equation 2.7: 
 2EZpa         (2.7) 
 
where   is the fine structure constantr, Z is the atomic number of the 
material and E is energy. 
 
 
Fig. 2.3: (a) Pair production electron and positron fproduced in the field of nucleus  (b) 
Annihilation process: electron and positron annihilate producing two photons each with 
energy 511 KeV. 
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2.2.4 Ionizing radiation field 
 
 
     
 
 
 
 
 
 
Fig.2.4: Radiation field producing fluence energy (Attix, 1986; ) 
 
  Φ =
𝑑𝑁
𝑑𝑎
 (da is the great circle area)   (2.10) 
 
Energy fluence: 𝛹 =   
𝑑𝐸
𝑑𝐴
    (2.10b) 
 
 
2.2.5 KERMA and its components 
A photon field with total energy Rin, u enters a volume, while Rout, u-rl 
is the energy leaving the volume: 
 
 
 
 
 
 
Fig. 2.5: Component of Kerma photon field with total in and out 
energy in a volume (Attix, 1986) 
 
 
The transfer of energy is given by Equation 2.11: 
 
𝜀𝑡𝑟 = 𝑅𝑖𝑛,𝑢 + 𝑅𝑜𝑢𝑡,𝑢−𝑟𝑙 + ∑𝑄     (2.11) 
 
where rl is release energy. 
Therefore, KERMA (kinetic energy release per mass) is in equation 2.11b: 
 
𝐾 =
𝑑𝜀𝑡𝑟
𝑑𝑚
= 𝛹
𝜇𝑡𝑟
𝜌
       (2.11b) 
 
Rout,u-
rl 
V 
 
Rin,u 
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Kerma includes all kinetic energy given to secondary electrons, and this 
energy may be lost by collisions and radiative losses. Therefore Kerma are 
subdivided into collision kerma (Kc) and radiative kerma(Kr). Kerma offers a degree 
of the energy loss per unit mass from photons causing collisional losses for 
secondary electrons (Fig.2.5). 
By definintion collision kerma is the estimation of the net energy exchange 
(equation 2.12) to charged particles per unit mass at the point of gain, rejecting both 
the radiative energy loss and energy delivered from one charged molecule to others.  
 
𝐾 =
𝑑𝜀𝑡𝑟
𝑛
𝑑𝑚
     (2.12) 
 
where 𝜀𝑡𝑟
𝑛  is the energy transfer i.e. the total kinetic energy of secondary 
electrons which is not lost as brehmsstrahlung. The quantity g of the fraction of 
energy lost as brehmstrahlung is called radiative loss as in euation 2.13 and 2.14: 
𝐾𝑒 = 𝐾(1 − 𝑔) = 𝛹
𝜇𝑡𝑟
𝜌
(1 − 𝑔)     (2.13) 
  
𝜇𝑒𝑛
𝜌
≡
𝜇𝑒𝑛
𝜌
(1 − 𝑔)    (2.14) 
 
𝜇𝑒𝑛
𝜌
:𝑚𝑎𝑠𝑠 𝑒𝑛𝑒𝑟𝑔𝑦 𝑎𝑏𝑠𝑜𝑟𝑝𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 
 
 
 
2.2.6 Absorbed dose 
 
The average energy imparted to matter per unit mass by  ionizing 
radiation is termed absorbed dose, and considers the transport of all energy 
(both charged and uncharged particles) through the region of interest (Fig.2.6). 
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Fig. 2.6: Average energy imparted to matter in and out of the volume expressed 
in euation 2.15: (Attix, 1986) 
 
 
𝜀 = 𝑅𝑖𝑛,𝑐 − 𝑅𝑖𝑛,𝑐 − 𝑅𝑜𝑢𝑡,𝑢 − 𝑅𝑜𝑢𝑡,𝑛 + ∑𝑄   (2.15) 
Therefore absorbed dose is expressed mathematically as in equation 2.16: 
 
𝐷 =
𝑑𝜀
𝑑𝑚
 ; unit: [Gy] = (J/Kg)      (2.16) 
 
 
2.2.7 Dose from Photons, CPE and TCPE 
 
 
 
Fig. 2.7: The role of CPE in the measurement of exposure 
(reproduced from Attix, 1986). 
 
 
Charged particle equilibrium (CPE) in radiation physics is defined as the 
equivalent quantity of charged particles leaving and entering a volume for every 
energy and kind of particles. The attainment of CPE in an ionization chamber, 
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however, allows the measurement of the ionization collected within a defined 
volume and mass of air, in place of the ionization produced everywhere by all the 
secondary electrons that start within the defined volume, as called for by the 
exposure definition. Therefore the absorbed dose measurement in the volume, V is 
equivalent to the collision kerma can be expressed mathematically in equation 2.17: 
 
𝐷 =
𝜀
𝑑𝑚
  
𝐶𝑃𝐸
→ 
𝜀𝑡𝑟
𝑛
𝑚
= 𝐾𝑐 = 𝛹
𝜇𝑒𝑛
𝜌
   (2.17) 
 
  
Similarly, transient charged particle equilibrium (TCPE) occurs when the electrons 
originating from upstream contribute to the doseas as in equation 2.18.) ,  
 
𝐷
𝑇𝐶𝑃𝐸
→   𝐾𝑐(1 + 𝐹𝑇𝐶𝑃𝐸)     (2.18) 
 
 
 
 
Fig. 2.8: Transient charged particle equilibrium for indirectly ionizing  
radiation .(Adapted from Attix, 1986) 
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2.3 Introduction to Radiotherapy 
Radiation treatment can be utilized to cure, control and ease side effects of 
tumors. Around half of all disease patients would profit by having radiation 
treatment during their sickness, and it is an imperative part of curing around 40% of 
cured malignancies (RANZCR 2014). Radiation treatment employs ionizing radiation 
to impair and ultimately destroy cells in its treatment of growth.  
In the event that radiation has the adequate energy to discharge at least one 
orbital electron from the particle or atom, the procedure is called ionization and the 
radiation is said to be ionizing radiation (Metcalfe et al 2003). Ionizing radiation can 
cause damage to DNA through direct and indirect interactions that may introduce a 
sequence of actions that lead to potentially deadly chemical and biological damage 
of the cell. Radiation treatment utilizes the repair and repopulation difference 
among tumour and normal cells, as tumour cells are less likely to repair than normal 
cells after exposure to radiation. 
In the treatment of cancer disease through radiation therapy, the point is to 
limit the radiation to the malignant area only, and reduce healthy tissue damage 
and complications. This is accomplished through external and internal beam 
radiation therapy. Photons and electrons are usually employed to deliver the 
radiation dose to the tumour area in terms of external beam treatment (Metcalfe 
et al 2003). The damage to the cell is identified as the measure of energy deposited 
in a specific mass of tissue, the absorbed dosage. The absorbed dose is measured in 
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Grays  (1 Gy = 1 J/kg). The greater the measure of radiation consumed by the tumor 
cells, the lower the likelihood of cell survival (Hall et al 2006). 
 
2.4 Stereotactic Radiation Treatment 
Stereotactic radiation treatment is a particular class of radiation treatment 
techniques that enable a high dose of radiation to be delivered to the cancer cells 
using a precisely focused method whilst sparing the healthy tissues. Stereotactic 
treatment includes the utilization of small radiation beams to treat the tumour target 
volume with high geometric and dosimetric exactness. There are various difficulties 
that exist under small field conditions, including the presence of horizontal charged 
disequilibrium, incomplete geometric shielding of the primary photon source, and 
detector volume averaging effects. Most complications and errors in patient 
treatment plans are as a result of uncertainties in small field measurements and 
calculation. Precise estimations of the measurement qualities, including output 
factors and beam profiles are required to ascertain the exact radiation approach. 
Traditional treatment of tumours with external beam radiotherapy is most 
frequently performed with a linear accelerator (linac). In external beam radiotherapy, 
the typical energy required in clinical practice, apart from treatment of superficial 
lesions or tumours, is more than one mega-electron volt (MeV). The linac accelerates 
a high energy beam of electrons to very high speeds (up to 99% of the speed of light) 
which are incident on target material ordinarily made of tungsten. X-ray beams are 
then discharged from the target as Bremsstrahlung (braking radiation), where 
accelerated charged particles transmit electromagnetic radiation because of the 
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deceleration and projection change of the electron as it nears the nucleus of the 
target atom. As the electron loses energy, the energy is converted into a photon via 
conservation energy laws (Bushberg et al. 2010). It is these x-rays that are used to 
irradiate the patient, with the potential to kill the cancerous cells. The drawback of 
this procedure is that normal tissue is additionally illuminated and damaged during 
the time of tumour treatment. As such, the description of tumour and target volumes 
for radiation therapy is vital to its successful implementation, requiring accurate 
characterisation of the location and size of the tumour.  
According to ICRU 62 (1999), there are three volumes in radiation therapy. The 
first is the location and extent of gross tumour, i.e. what can be seen palpated or 
imaged; this is known as the gross target volume (GTV). The clinical target volume 
(CTV) increases the GTV to allow for microscopic spread of the disease in surrounding 
tissue and areas of clinical risk such as lymph node groups. The third volume, the 
planning target volume (PTV) contains the CTV, plus a margin to allow for 
uncertainties in planning or treatment delivery and organ movement (Fig. 2.1). The 
PTV ensures that the radiotherapy dose is delivered to the CTV (ICRU 62, 1999). The 
importance of defining an accurate PTV is exemplified within small field treatments 
such as stereotactic radiation therapy/surgery. 
 
2.4.1 Stereotactic Radiotherapy and Radiosurgery (SRT/SRS) 
The goal of radiotherapy is to deliver a large radiation dose to a target volume 
while minimising the dose to surrounding normal tissue. Stereotactic 
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radiosurgery/therapy (SRS/SRT) is the use of radiation ablation using very precisely 
focused radiation beams in place of conventional surgical excision to remove or 
create fibrous tissue in small target volumes (Wong 2011, Ruud 2009, Podgorsak 
2005, Taylor 2011). Through the increased accuracy and precision of linacs, and the 
continual development and advancement in tumour localisation accuracy, the use of 
stereotactic radiation for treatment of small lesions has become more abundant 
(Taylor et al., 2011). Usually, SRS is used to treat brain or spine tumours, or other 
irregularities in a single fraction. SRS has also progressed into SRT, where stereotactic 
treatments are performed over multiple fractions to treat tumours.  SRT is used to 
treat tumours in various situations, including tumours that have been defined as too 
large to treat in the one fraction (as this would cause an unacceptable level of normal 
tissue toxicity) or tumours near important structures. 
Lars Leksell in 1951 formulated the term stereotactic radiosurgery with the aim 
of developing a technique for the non-invasive damage of intracranial lesions that 
may be inaccessible or inappropriate for open surgery (Chine 2008). The technical 
realisation of this principle allowed Leksell to develop the gamma knife in 1967 (Fig. 
2.3). The gamma knife is dedicated to stereotactic radiosurgery, whilst a linac is not. 
The equipment used to conduct SRT and SRS deliver radiation with a high precision. 
To be effective it is also needs to be based on accurate delineation of targets via 
computed tomography (CT), magnetic resonance imaging (MRI) and angiography of 
the brain. These imaging systems are able to achieve 3D or 4D volume 
reconstructions, so that the tumour and surrounding structures can be visualised 
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accurately. Technological improvements in scientific imaging and computing have led 
to increased medical adoption of stereotactic treatment. In 2004, 45% of clinics in the 
United States offered SRS treatment, according to an AAPM profile of radiation 
oncology departments (AAPM 2004). In 2014, at least 12 major hospitals in Australia 
offer SRS. 
Stereotactic radiation treatment is beneficial as the beam can be confined very 
precisely to the lesion, reducing radiotoxicity to normal tissue, and accomplishing 
dose reduction, especially to critical structures (Grebe 2001). Owing to the difficult 
conformation of the radiation beam to the tumour location and the relative smaller 
sizes of the tumour, higher doses of radiation can be used relative to standard 
radiotherapy, consequently improving the probability of local tumour control. This 
can also be described as a relative increase in therapeutic ratio, which is the ratio of 
tumour control to normal tissue complications. However, the close margins around 
the CTV used in stereotactic radiation treatment also increase the complexity of the 
delivery. Due to the relatively high doses used and highly conformal dose profiles, set 
up or localisation errors in the order of a few millimetres can cause severe under 
dosing of the target and overdosing of adjacent organs at risk (OAR). SRT/SRS quality 
assurance (QA) is therefore increasingly important with very tight linac machine 
tolerances, i.e. radiation and mechanical isocentre coincidence, couch top and 
imaging system precision (Tyler et al 2013, Rowshanfarzed et al 2011). Incorrect 
output factor and profile calibration of linacs has caused the incorrect treatment and 
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overdose of patients  in the US, in Florida (77 patients), Toulouse (145 patients) and 
Springfield (152 patients) (Schofield 2012). 
 
2.5 Stereotactic Ablative  radiotherapy (SABR) 
SABR originates from stereotactic radiosurgery (SRS), firstly defined by Lars 
Leksell as a technique for carrying out high dose rate of radiation daily to intracranial 
neoplasms (Robertson et al 1951). The rationalization for utilizing SABR is its 
similarity to SRS, because giving a considerable dose over a small  fractions (hypo-
fractionation) tends to yield a good biological effect (Benedict et al 2010 and 
Timmerman 2008). 
The capability to give the preferred dose above a single or few (i.e. 1 to 5) 
fractions of radiation exposure with enhanced focusing on exactness and dosimetry 
which involves steep dose gradient give the establishments of SABR (Potters et al 
2004). Moreover, SABR has been considered at positively for both vital and 
metastatic disease when equalled with surgery regarding tomour control rates 
(Benedict et al 2010). In 1995, Blomgren et al published the first-ever data on SABR 
results. In total, 31 patients, with 42 tumours found in the liver, lung or 
retroperitoneal space experienced 80% local control with no further disease 
development during the survey time of 1.5 to 38 months post-treatment, with 51% 
of tumours diminished in an estimate or vanished (Blomgren et al 1995). 
From that point forward, there have been various articles on the results of 
SABR for  lung, liver and spinal tomour treatment. Preliminary evaluation  of lung 
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and liver treatments started in Germany and review journals providing details 
regarding the safety and exactness of SABR were developing, prompting planned 
Phase I/II trials (Wulf et al 2001, Herfarth et al 2001, Herfarth and Debus 2004, 
Timmerman et al 2003, Whyte et al 2003, Fukumoto et al 2002, Hara et al, 2002, Lee 
et al 2003, Nagata et al 2002, Onishi et al 2004 and Uematsu et al 2003). Published 
data has also increased for the treatment of spinal lesions utilizing SABR (Foote et 
al 2011, Benzil et al 2004, Bilsky et al 2004, Chang et al 2004, Ryu et al 2003 and 
Chetty et al 2013). 
SABR has changed the direction of radiation treatment for various disease 
area, especially for those patients determined to have non small cell lung cancer. It 
offers the patient a treatment that requires less planning  and advances the 
therapeutic group with the ability to achieve the low normal tissue destructiveness 
and high limited control rates identified with medical procedure  or surgery (Ryu et 
al 2004). 
 
2.5.1 Hypo-fractionation 
Hypo-fractionation is the procedure of intensifying dose delivered to  the 
tumor in fractions and reducing the quantity of each fractions. Hypo-fractionation is 
not another hypothesis, nor is it relevant towards each kind of disease or 
circumstance. Hypofractionation was the fundamental fractionation plan utilized for 
radiation treatment techniques. Radiation treatments being essential, the dose was 
typically given to the skin as opposed to hidden situated tumors, and treatment was 
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given in a single fraction. Conversely, this radiation treatment method was stopped 
rapidly because of the development of late effects. As the name implies, late effects 
are reactions from the radiation that show up a few weeks after radiation treatment, 
as opposed to early effects which are normally connected with damage to vascular 
tissue, mucosa or epithelial covering(Timmerman 2008). 
These practices prompted the development of radiation treatment therapy in 
fractions. In 1951, Robertson et al detailed outcomes from their  research into head 
and neck malignancy treatment where the decision of fractionation relied upon 
tomor measurement and the last dosage to the tumour relied upon a progressing 
response to treatment in a particular case like mucositis. This was confirmed by 
Timmerman several years after. (Robertson et al 1951 and Timmerman 2008). 
Excitement was created over the superior outcomes and was credited to the 
extended fractionation technique. Radiation oncologists in this manner ventured far 
from utilizing hypo-fractionation until the 1950's, when neurosurgeon Lars Leksell 
researched the application of hypo-fractionated radiation treatment to radio-
resistant central nervous system (CNS) ((Robertson et al 1951 and Timmerman 2008).  
Typically, immeasurable single doses remained unbearable for the patient 
owing to the late effects previously mentioned, but the fundamental methods were 
investigated by Leksell by taking into consideration the application of technology that 
is inflexible in immobilization, which modified the daily dose in which the radiation 
was given (Timmerman 2008). Ordinarily, treatment fields were greater than the 
tumor and incorporated a noteworthy volume of the encompassing normal tissue 
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(Timmerman 2008). On the other hand, Leksell attempted to ensure that a lot of 
healthy tissue encompassing the tumour, got as small dose as could be expected 
under the circumstances. The fundamental ordinary tissue that was then harmed was 
tissue particularly bounding the tumor or tissue that was treated as a result of poor 
dosimetry. Leksell remarked that if this area of typical tissue delievry measurement 
was adequately negligible, the patient did not encounter symptomatic clinical 
lethality, even as a late impact (Curran et al 1990 and Timmerman 2008). This brought 
about SRS, a viable and suitable method of treating patients with intracranial disease, 
and as examined prior, prompted the utilization of SABR for extracranial sites.  
 
2.6 SABR Treatment Planning 
As treatment approach assumes an imperative part in Stereotactic ablative 
radiotherapy planning, there are specific arrangement qualities and limitations that 
are essential. The goal of SABR is to deliver ablative doses to the target volume while 
sparing surrounding tissues while having steep isotropic dose fall-off.  
 
2.7 Treatment Delivery Techniques 
2.7.1 Three dimensional conformal Radiotherapy (3-DCR) 
Three dimensional conformal radiation (3-D) treatment is the most regularly 
utilized treatment technique for radiation therapy oncology group (RTOG) practices 
(RTOG 2011, 2012) to give lung SABR. For hypo-fractionated systems, the quantity 
of x-ray beams needed drastically increments because of the higher day by day dose 
and the significance set on day by day dosage to typical tissues (Ng et al 2014). The 
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arrangedment of beam for coplanar and non-coplanar for 7-11 beams can be 
utilized to fulfil all dose limitations for hypo-fractionated treatment of  lung cancer. 
On the other hand, the European Organization for Research and Treatment of 
Cancer (EORTC) suggests utilization of just coplanar beams, with the utilization of 
non-coplanar beams considered appropriate if dose limitations cannot be met. This 
is because of tumour movement in SABR, and the expanded treatment time brings 
about the probability of more noteworthy intra-fraction motion (Purdie et al 2007). 
Conversely, when examining low dose measurements, coplanar beams may 
expand "dose bathing" (expanded volume of low and transitional doses), and a non-
coplanar beam technique can have less deviation from suggested protocols (Lim et 
al, 2010). In 2010 Lim et al reported that plans with 5, 7, 9,11, 13 or 15 beams for 
coplanar or non-coplanar fulfilled high dose measurement and the limitations of 
organ at risk, yet non-coplanar beams were needed to achieve the small dose 
limitations (Lim et al 2009). Similarly, Fakiris et al (2009) gave an account of utilizing 
10-12 non-coplanar, non-contradicting x-ray beams to accomplish SABR 
requirements. These articles nevertheless do not represent tissue heterogeneity in 
treatment planning dose computation (Xiao et al 2009). 
In 2003, Webb asserted the important of using Intensity modulated radiation 
therapy (IMRT) in delivering a uniformless radiation fluence. There have been few 
studies providing a complete characterisation on SABR treatment for lung using 
IMRT. IMRT, as 3DCRT, can utilize coplanar and non-coplanar bars for hypo-
fractionated treatment of lung disease. The Netherlands Cancer Institute detailed a 
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predefined class course of action of either 9 coplanar beams of IMRT or 12 to 16 
non-coplanar beams, endeavoring to reduce area of the skin that is covered (Holt et 
al 2011). They accomplished a predominant R50% result for the non-coplanar IMRT 
when compared with coplanar IMRT. The Cleveland Clinical Foundation have 
similarly revealed a SABR plan technique that uses a type of 7 non-coplanar, non-
limiting conversely planned beams (Videtic et al 2010); but, no firm consideration of 
beam array correlation was specified. 
In 2010, Le et al reported a lung SABR procedure using 6 to 8 non-coplanar 
IMRT beams. The incidence aangles at gantry position were noto determined,  and 
the quantity of division on each beam was restricted  to 5 to reduced the effect of 
interaction.  
Volumetric modulated arc therapy (VMAT) is comparable to IMRT in that it is 
equally planned, but as opposed to giving the radiation utilizing static fields, VMAT 
incorporates the steady delivery of  dose measurement while the linac pivots the 
patient, offering the ability to modify dose rate and gantry speed all through 
treatment (Bedford and Warrington 2009).  
The benefit of VMAT over IMRT is the treatment time and less scattered dose 
to the body. It also contributes to the greater efficiency of the VMAT technique. so 
the test of picking the perfect static gantry angles ejected (Elith et al 2011). 
However, preventative measures should be incorporated,  ensuring healthy tissues 
are not getting unwanted or avoidable dose along with treatment. The benefit of 
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VMAT over IMRT is because of its non-static angle method, consequently, the 
difficulty of choosing the ideal static gantry angles is removed (Elith et al 2011). 
However, cautionary measures need to be applied, ensuring healthy tissues 
are not getting undesirable, avoidable dose during treatment. In order to prevent 
double-dosing the healthy tissue, fractional arcs are the preferred option. As an 
example, research has indicated that 2 halfway arcs are made with a revolution of  
204° degree (Chan et al 2011). The primary revolution is not clockwise from 179° to 
335° gantry point, at which point a clockwise circular segment from 335° to 79° was 
utilized to restrain the contralateral lung parenchyma dose. This distribution of a 
different beam of arrays was the plan for a left lung tumor, but a right-sided tumor 
got the angles reflected (Chan et al 2011). Although Chan et al did not carry out this 
treatment using a SABR  approach,  the limiting method of dose to the contralateral 
lung are quite similar.  
Additional investigations (Brock et al 2012, Palma et al 2012) have illustrated 
utilizing an arc greater than 358o segments against treatment. They also, observed 
that because of the higher partial dose measurement, numerous distributions of a 
similar arc might be needed, because their linac restrictions needed individually arc 
segments to have less  than 999 MU, with most situations utilizing complete 5 arcs. 
Holt et al described a double incomplete arc method for delivering  18 Gy dose per 
fraction for a SABR plan of a lung.  The length of the arc between 80° to 264° was 
utilized to decrease dosage to the contralateral lung. Similarly, to Le et al, they 
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reported utilizing an acceptable spacing of 4o for the gantry as there remained no 
apparent change in planning since the last revolution was under 4o.  
 
2.7.2 3DCRT and IMRT Treatment Quality 
 
In order to increase dose conformation so as to improve the sparing of 
healthy tissues while increasing the quality of treatment, three dimensional 
conformal radiotherapy (3DCRT) was developed in the early 1990s. The purpose was 
to exploit the possible improvement for living tissues, owing to better three-
dimensional localisation of the high dose volume (Webb, 1998c). 
Traditionally, 3DCRT is said to be “conformal” as a result of the mode of beam 
apertures which are designed by a beam’s-eye view (BEV) of the target. 
Nevertheless, even the use of a very large number of such conformal beams does 
not imply that the dose will conformably surround the target volume. The problem 
is that the BEV of the anatomy does not give any indication of the 3D shape of a 
structure, since all that is seen is a projection of the shape from each angle. 
Typically, 3D-CRT are sub-divided into two main techniques: the geometrical 
field-shaping; and the modulated intensity of fluence across the geometrically-
shaped field. Therefore, intensity modulated radiotherapy (IMRT) is embedded in 
3D-CRT. For sensitive structures that are adjacent to or near the high-dose regions, 
3DCRT increases the conformity of the treatment dose levels to the well-defined 
target volume. The conformity of high dose to all but very simple target volumes 
was not always achievable until the recent availability of IMRT. Intensity-modulated 
radiation therapy (IMRT) is a developed practice of 3DCRT. 
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In contrast to 3DCRT, IMRT creates a wide-ranging 3D view of the object, as 
opposed to the reformation of a sequence of 2D projections, to generate a true 
conformal dose distribution including convex targets for planning purposes. Its 
development and acceptance into general clinical practice signifies one of the most 
substantial developments in radiotherapy treatment planning and transfer 
technology (Metcalfe et al., 2007).  
IMRT techniques are usually delivered with photon beams. However, 
selection of photon-beam energy is usually proportional to the exact case to be 
treated. In most clinical conditions, a beam-energy plan similar to that used for 
3DCRT is adequate for IMRT to achieve a superior dose distribution (Hunt et al., 
2002). However, Welsh et al. (2007) reported that despite their skin-sparing 
potential, high-energy photons (>10MV) are not recommended in IMRT treatment. 
The main concern is that some planning systems may not effectively model the 
“beam narrowing” at depths observed with the high energy photons and small 
radiation beamlets encountered in IMRT. This occurrence is caused by lateral beam 
degradation due to penumbra widening; when very small fields are used, there is 
greater loss of electron equilibrium laterally with higher-energy photons (Welsh et 
al., 2007). The other concern about using high energies for IMRT is the neutrons 
present above 10 MV (NCRP-151). In 2004, Health et al., and Li et al., (2009) 
identified that most IMRT beams also use multiple beam angles; with increasing 
beam directions and lower beam weights for each beam, it is understood that the 
extra penetration at high energies becomes less of an advantage. Because IMRT 
32 
 
often employs high MUs, the extra multi-leaf-collimator (MLC) leaf leakage at high 
energies also needs to be accounted for. While none of these issues alone impede 
the practice of IMRT at higher x-ray beam energies, most centres have invested 
considerable time and effort into commissioning their IMRT beams on the 6 MV x-
ray beam energy (Health et al., 2004; Li et al., 2009). Presently, in Peter MacCallum 
Cancer Centre, Melbourne, 6MV photon is the most often used beam energy for 
IMRT treatment, while 10MV photon is sometimes used for the treatment of deep-
seated tumours such as prostate cancer. 
Though IMRT is a relatively old treatment technology, intensity-modulated 
deliveries, first with a simple block or a physical wedge to produce a slope of 
intensity across a field, have been produced for many years. This delivery 
technology, including metal compensators, can be considered as the source of 
IMRT, as it is also grounded on the hypothesis of optimising intensity shapes with 
photons (Chang et al 2004). Notwithstanding its comparatively short history of 
clinical usage, IMRT is now extensively used due to its numerous benefits  over 
conventional 3CDRT. Inverse-planning techniques that define IMRT distributions, 
which greatly improve the generation of an IMRT plan, have become readily 
available for clinical purposes. Inverse planning generates a superlative set of 
intensity-modulated beams (IMBs) from the model dose prescription (or a 
statement of dose objectives) (Corletto et al 2003). Inverse planning does not 
usually define a mode of treatment delivery, though restraints on the existing 
delivery apparatus could be incorporated into these calculations. 
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IMRT treatments for small, high-dose volumes with large low-dose areas 
usually result in less target volume coverage and more damage to healthy living tissue 
compared to a conventional and less conformal approach. This raises serious concern 
about IMRT treatment procedures (Change et al 2004). In 2006, Randall asserted that 
the ambiguity in the instantaneous position of the tumour in the course of treatment 
can lead to non-malignant volumes getting the high dose planned for the tumour 
volume. Inter-fraction as well as intra-fraction target volume relative to reference 
landmarks, joined with setup errors and other imprecisions, add to this uncertainty. 
The established standard approach has been to add margins to the target volume, 
usually at the expense of most of the possible benefits of the above precise 
treatment-delivery techniques. Recently, though, the development of image 
guidance, including cone beam computed tomography (CBCT), has enabled imaging 
of some critical anatomy just prior to patient treatment on a linac (Podgorsak, 2005). 
As a final point, the introduction of image fusion of CT, MRI, SPECT and PET make 
possible the accurate delineation of target and normal structures. This is now 
becoming a common way to avoid geographical misses in RT.  The accuracy of 
treatment delivery can also be improved by accurate commissioning of both the linac 
and the planning system. This can be helped by the accurate and precise 
measurements of the commissioning data collection, which demands the selection of 
proper dosimetry tools and guidance about their appropriate use. 
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2.8 Patient specific quality assurance (PSQA) 
Patient specific quality assurance (PSQA) treatment is a plan dose build-up, 
free of the treatment planning system. This can be performed by dosage 
computations, direct measurement of dose, or a mix of both. The exactness and 
speed of 3 dimensional (3D) dose computation have been significantly enhanced in 
recent years as computational power has expanded. Basic pencil beam algorithms 
have developed into more advanced collapsed cone algorithms, and Monte Carlo 
estimations were presented as calculation time was reduced considerably (Olson et 
al. 2012, Boggula et al. 2011, Thoelking et al. 2015). However, while high precision 
dose computation algorithms are accessible, dose estimations within the verification 
method are not yet viewed as important, as an estimation can give a full 
representation of the effect of treatment planning and treatment machine 
inconsistencies on actual dosage. The verification of established dose on 
measurements can be performed with a wide variety of dosimeters (Chan et al. 2014, 
Nelms et al. 2011). 
Previously, when linacs were presented for external beam radiotherapy, point 
measurements were done. Straightforward point measurements however are limited 
for dose verification measurements of complex dose build-ups with high dose 
gradient, for example, for IMRT. This has been overwhelmed by the presentation of 
2D dose estimations with radiographic films (Nelms et al. 2011, Zhen et al 2011). Film 
measurements permit a 2D plane to be checked, but are restricted to certain planes, 
and the dose assessment is an unwieldy technique which lessens the efficiency of the 
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QA method. For an entire 3D dose check, 3D detectors including gel and solid plastic 
dosimetry have been created (Stasi et al. 2012). These procedures take into account 
an entire 3D dose verification but are labour intensive and cannot be performed in 
nor easily moved to the real patient geometry. To check a dose build-up in patient 
geometry in light of measurement utilizing fluence modelling, two distinctive 
techniques have been established. The conversiontal method contrasts the measured 
detector response and the normal detector response in the validation geometry and 
corrects with the computed dose in patient geometry utilizing beam approaches (Yan, 
2010). 
The second approach utilizes the measured detector response to rebuild the 
fluence with which the dosage is recalculated in patient geometry by a dose 
mechanism (Chan et al. 2006, Vrancic et al. 2009, Murthy et al. 2011, Heijkoop et al. 
2014, Siewerdsen and Jaffrey 2001). In this approach, an independent fluence model 
computes the projected fluence in view of a radiotherapy treatment plan (RTplan). 
This computed fluence is utilized to define the normal detector response in view of a 
detector model. By contrasting this computed detector response and the measured 
detector response, the computed fluence would then be able to be corrected by the 
measurement. 
Lastly, the corrected fluence is utilized to recalculate the measurement dose 
in a CT characterising the patient geometry which can be contrasted with the 
recommended dosage, allowing for a  3D in vivo dose check. The two most basic 
detector classes accessible and utilized for fluence modelling are the electronic portal 
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imaging device (EPID) and 2D detector arrays made out of ionization chambers. The 
EPID detector comprises a scintillating screen that produces photons when hit by x-
ray beams, tracked by detection of these photons in an amorphous silicon plate. The 
radiated light is then able to be utilized to model fluence. The EPID detector was 
initially presented as a position check device, yet broad research has prompted the 
improvement of complex fluence modelling in view of EPID dosimetry (Oelfke et al; 
2016).  
The main advantage of an EPID detector is its high resolution and its position 
inside the treatment machine behind the patient, permitting estimation-based 
fluence modelling throughout patient treatment. This advantages however has a 
drawback in that distinctions in expected and measured detector response can start 
from the treatment machine, the patient geometry or both. Unfortunately, as this 
system is not yet comprehensively economically accessible, only departments with 
broad learning on EPID dosimetry can utilize this method for dose check purposes.  
Typically, industrially accessible dose verification devices utilize detector 
arrays, diodes or ionization chambers. In contrast with EPID dosimetry, 2D detector 
arrays are usually attached on the linac or situated on the treatment table outside a 
patient set up, which prevents the proficiency of fluence modelling in view of real 
patient treatment delivery (Van 2004, Murthy et al. 2011 and Heijkoop et al 2014). 
Although current 2D detector arrays have a limited spatial resolution, research has 
demonstrated that high resolution dose verification can be performed utilizing low 
resolution measurement (Van et al. 2007), and new detectors are as yet being 
37 
 
produced permitting fluence modelling throughout patient treatment (Ding et al. 
2007). However, pre-treatment dosage checks built on 2D measurements are an 
unwieldy approach as the check is performed preceding the actual treatment and 
needs the officially restricted linac time. With the expansion in the quantity of 
patients that require a 3D dosage check, proficient and solid pre-treatment dose 
verification techniques are required.  
A vital part of the pre-treatment dosage check is the assessment of 
experimental dose changes. From a clinical perspective, under-dose in tumour tissue 
ought to be limited to keep up adequate tumour control and over-dose in both the 
tumour and normal tissue averted to limit health-related illnesses for the patient. 
Generally, dose changes are assessed using percentile dosage differences, and 
distance-to-agreement for a 2D plane (Nelms et al 2011). These have been effectively 
joined to bring about the gamma assessment (Yang et al. 2007). The gamma 
assessment provides an effective dose assessment method as it permits a quick 
assessment of dosage contrasts in both 2D and 3D (Simon et al. 2015, Moteabbed et 
al 2014). However, the gamma assessment is underlined by a weak correlation 
between dose differences and dose volume histograms (DVH's) (Yan 2010, Veiga et 
al 2014, Castadot et al. 2008, Mencarelli et al. 2014). Therefore, pre-treatment dose 
verification in view of DVH's will bring about a more clinical PSQA technique. Clear 
dose volume histogram (DVH) criteria are as yet undefined. 
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2.9 Radiation Dosimetry 
2.9.1 Absolute radiation dosimetry 
 
The direct measurement of a radiation dose in a dosimeter cavity or material, 
with no requirement for calibration of the dosimeter response in a known radiation 
field, is referred to as absolute radiation dosimetry. Ionizing radiation are measured 
with radiation dosimetry systems that comprise a radiation dosimeter and a reader. 
The radiation dosimeter has two parts: a cavity made out of a radiation sensitive 
medium and a wall encasing the cavity. The cavity creates a signal with respect to 
ionizing radiation, the wall comprises the cavity medium, and the signal response is 
measured using the  reader. The radiation amounts frequently measured in the 
radiation dosimeter cavity are: (a) the absorbed dose; and (b) the fluence particle. 
The absorbed dose in the dosimeter cavity has two categories: absolute and relative.  
The three known absolute radiation dosimetry systems are: (I) calorimetric 
total dosimetry, (ii) chemical (Fricke) total dosimetry, and (iii) ionometric (ionization 
chamber-based) supreme dosimetry. They are well explained in relation to their 
application in radiotherapy in Podgorsak 2017. The primary characteristics of the 
three known absolute radiation dosimetery systems are presented in Table 2.1. 
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Table 2.1: Principal characteristics of the three known absolute radiation dosimetry 
(Podgorsak, 2016) 
  
Absolute radiation 
dosimetry systems 
Calorimetric 
radiation 
dosimetry 
Chemical radiation 
dosimetry 
Ionometric radiation 
dosimetry 
Cavity material Water or graphite Ferrous sulphate 
solution in water 
Air 
Reaction in cavity Ionization and 
excitation 
Oxidation Fe2+ → 
Fe3+ 
Ionization and 
production of 
positive and negative 
ions 
Dosimetric signal in 
cavity 
∆𝑇 change in 
cavity 
temperature 
∆𝑀 = 𝐶𝐹3+change 
in molar 
concentration 
Ionization charge or 
ionization current 
Absorbed dose ?̅?cav 
in cavity 
?̅?cav = 
𝐶∆𝑇
1−𝐾
 ?̅?cav = 
𝐶𝐹𝑒
3+
𝑃𝐹𝐺(𝐹3+)
 ?̅?cav = 
𝑄𝑠𝑙𝑡
𝑚𝑎𝑖𝑟
(
?̅?
𝑒
)air 
Important parameter 
for absolute radiation 
dosimetry 
 G(X) = G/(100eV) 
G = G(X) x 1.037 x 
10-7 mol/J 
(
?̅?
𝑒
) 𝑎𝑖𝑟 = 33.97𝐽
/𝐶 
Measurement 
instrument(reader) of 
the dosimetry system 
Thermistor with 
Wheatstone 
bridge to measure 
rise in 
temperature 
Spectrophotometer 
to measure 
transmission of U.V 
light (303nm) 
through Fricke 
solution 
Electrometer to 
measure ionization 
charge or ionization 
current. 
 
 
 
2.9.2 Relative Dosimetry  
 
A relative dosimetry system is defined as a system that requires adjustment 
of its response in a known radiation ﬁeld. This sub-section highlights relative 
dosimetry systems that are of practicable importance to medical physics and are 
utilized as a part of radiation medicine for standardization of high technology 
equipment utilized for diagnostic imaging or treatment of disease with ionizing 
radiation. 
There are four classifications of relative dosimetry that are utilized as a part 
of radiation medicine: (a) ionographic, (b) luminescence, (c) semiconductor, and (d) 
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ﬁlm. Each of these general classifications is divided into a number of subcategories 
and each of the subcategories can be classiﬁed as either an active or passive/inactive 
dosimetry system.  An active dosimeter is electrically linked with the read-out 
system and its response signal is read directly during irradiation. In comparison, a 
passive dosimeter deposits the radiation-induced signal response during exposure 
to ionizing radiation, and measures the absorbed dose subsequently to irradiation 
when the dosimeter is linked to the read-out system for reading.  The principal 
characteristics of the commonly used relative dosimetery methods in radiation 
therapy are presented in Table 2.2.  . 
 
Table 2.2:  Characteristics of commonly used relative dosimetery methods in radiation 
therapy (Podgosark 2017) 
 
 
 
 
 
S/N Category of dosimetry 
system 
Dosimeter Mode 
1 Relative ionometric 
dosimetry 
Parallel-plate ionization 
chamber 
A 
   Thimble (cylindrical) 
ionization chamber 
A 
    Area survey meter (ionization 
chanber) 
A 
    Re-entrant well ionization 
chamber 
A 
2 Luminescence 
Dosimetry 
Thermoluminescence (TL) P 
    Optically stimulated 
luminescence (OSL) 
P 
3. Semiconductor 
dosimetry 
Diode (p-n junction) A 
   Diamond dosimeter A 
4. Film dosimetry Radiographic film P 
  Radiochromic film P 
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Table 2.3:  Radiation induced process and cavity medium in Relative dosimetery 
methods in radiation      therapy (Podgosark 2017) 
 
Relative dosimetry 
  
Cavity medium Radiation induced process 
Ionometric Ionization chamber Air Production of ion pair 
 Ionization chamber Liquid Production of ion pair 
Luminescence  Thermoluminescence  Crystalline solid Phosphorescence emission 
accelerated by heat 
  Optically stimulated 
luminescence (OSL) 
Crystalline solid Phosphorescence emission 
accelerated by heat 
Semiconductor Silicon diode Si p-n junction Production of electron-
hole pair 
  Diamond detector Diamond (carbon) Production of electron-
hole pair 
 Film Radiographic Silver bromide Reduction of silver ion 
(Ag+) into silver atom 
(Ag0) 
  Radiochromic di-acetylene Polymerization od di-
acetylene monomer into 
polymer. 
        
 
 
2.10 Radiation dosimeters 
A system that either directly or indirectly measures or assesses the amount 
of exposure, kerma, absorbed dose or equivalent dose, or their time rates or 
connected amounts of ionizing radiation is referred to as a radiation dosimeter. A 
dosimetry system is simply a combination of dosimeter and reader. The procedure 
of finding the value of the experimental quantity by measurement of a dosimetric 
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quantity using a dosimetry system is called dosimetric quantitation. The result of a 
measurement is the rate of a dosimetric quantity expressed as the results from a 
numerical value and a suitable unit. Consequently, to be characterised as a radiation 
dosimeter, the dosimeter should own as a minimum one physical property that may 
be a characteristic of the measured dosimetric magnitude and that can be used for 
radiation dosimetry with proper linearity.  In order to be useful, radiation dosimeters 
should exhibit numerous suitable characteristics. For example, in radiotherapy 
specific information of each, the absorbed dose to water at a detailed point and its 
spatial distribution is of importance, in addition to the opportunity of deriving the 
dose to an organ of interest in the patient. In this context, the desirable dosimeter 
properties could be characterized by way of accuracy and precision, linearity, dose 
rate energy, and directional independence as well as spatial resolution. However, 
not all dosimeters can satisfy all characteristics. The selection of a radiation 
dosimeter and its reader should, therefore, be made cautiously, taking into account 
the requirements of the measurement condition; for example, in radiotherapy, 
ionization chambers are recommended for beam calibrations, and other dosimeters, 
such as those discussed below, are suitable for the evaluation of the dose 
distribution (relative dosimetry) or dose verification (Podgorsak, 2005). 
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2.10.1 Properties of clinical Dosimeters 
2.10.1.1 Accuracy and precision 
In radiotherapy dosimetry, the uncertainty related to the measurement is 
frequently expressed in terms of accuracy and precision. The precision of dosimetry 
measurements specifies the repeatability of the measurements under comparable 
conditions, and may be assessed from the data acquired in repeated measurements. 
The spread of the measurement results is related to high precision with a slight 
standard deviation. The accuracy of dosimetry measurements is the contiguity of 
their expected value to the reality of the measured amount.  
The outcome of such measurements cannot be absolutely correct and the 
incorrectness of such a result is quantified as uncertainty. The uncertainty here best 
explains an element that defines the spread of the measured values of a quantity; it 
could be evaluated by statistical methods with a variable ‘X’ or by other methods ‘Y’, 
has no known sign and is usually presumed to be regular. The difference relating the 
measured value of a quantity and the real or true value of that quantity is the actual 
error of measurement (Podgorsak, 2005).  
 
2.10.1.2 Spatial resolution and physical size 
Due to the fact the dose is a component quantity, the dosimeter ought to 
allow the determination of the dose from a totally small volume (i.e. one desires a 
‘absolute dosimeter’ to characterise the dose at a point) The region of the point in 
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which the dose is situated (i.e. its spatial region) need to be properly defined in a 
reference coordinate point (Podgorsak, 2005). 
Typically, TLD dosimeters come in very small dimensions and their use, to a 
great extent, approximates a point measurement. Film dosimeters have excellent 2-
D (two-dimensional) and gel dosimeters have 3-D (three-dimensional) resolution, 
wherein the point measurement is controlled only by the resolution of the 
assessment system. Ionization chamber type dosimeters, are of limited size to give 
the required sensitivity, although the new type of pinpoint micro-chambers partially 
overcomes this problem. 
 
2.10.1.3 Convenience of use 
While some dosimeters are fundamentally of the integrating type, (TLDs and 
chemical dosimeters (gels) are examples of such), others can be measured in both 
integral and differential methods (e.g. ionisation chambers) (Podgorsak, 2005). 
Direct reading dosimeters (e.g. ionization chambers) are generally more convenient 
than passive dosimeters (i.e. those that are read after due processing following the 
exposure, for example TLDs and films). They are reusable, with no or little change in 
sensitivity within their lifespan. Semiconductor dosimeters are also reusable, though 
with a slow fadeout of sensitivity within their lifespan. On the other hand, some 
dosimeters (films, gels, and alanine) are not reusable. These dosimeters measure 
dose distribution in a single exposure (e.g. films and gels) and are sensitive to 
handling (e.g. TLDs and alanine) (Podgorsak, 2005). 
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2.10.1.4 Fading 
Inherent loss of signal of a dosimeter after some time is referred to as fading. 
This fading is of two types, the short and long term. Distinctive dosimeters have 
diverse fading components and semiconductor dosimeters fade through 
unconstrained discharge of electrons from traps.  In the case of OSL, this can be 
improved through a non-zero surrounding light level, and as such, OSLDs have 
critical short term fading (Fig. 2.9). The preservation of signal after stabilizing 
however is high for OSL, with a dosimeters standard reading reducing by 
approximately 1.8% from 17 to 38 days after exposure to radiation, although 
steadying after 27 days. 
 
Fig. 2.9: Graph of fading of Al2O3: C OSLDs over time ( reproduced from   
Jursinic, 2007). 
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2.10.1.6 Sensitivity 
The connection between detector signal and incident radiation under similar 
conditions is not generally predictable. Frequent utilization of a similar dosimeter 
can cause radiation loss to the system, diminishing the signal estimated for each 
ensuing reading. For OSL, this is caused by pulverization of the traps few electrons 
to be trapped and therefore less light yielded on readout. This is shown in Fig. 2.10 
from Wesolowska et al 2017 in which detectors were irradiated to 100 and 400cGy 
100 times and read after every irradiation, a reasonable loss of signal response can 
be seen over the readings. 
 
 
Fig.2.10: Loss of sensitivity of OSL through multiple readings (reproduced from 
Wesolowska et al 2017) 
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2.10.1.6 Angular dependence 
 
The reaction of dosimeters can fluctuate depending upon their introduction 
to the radiation field; this is referred to as directional dependence. Directional 
dependence is typically due to the because of the detector development, and is an 
element of the incident energy. It is an inbuilt property of the system and should be 
represented in detector usage (Podgorsak, 2005).   
In OSLs, the angular dependence of Al2O3:C dosimeters should be 
painstakingly considered in their clinical application. Readings were found to drop 
by as much as 70% for 25kVp mammography readings and 10-40% for X-ray and CT 
estimations, with the minimum difference detected for CT (Al-senan and Hatab, 
2011). In another report by Kerns et al 2011, a 4% and 3% diminishment in reading 
was realised for 6 and 18 MV beams respectively, which was found by utilizing Al2O3: 
C dosimeters and 6 MV radiation fields (Jursinic, 2007). This suggests that for clinical 
dosimeters, Al2O3: C dosimeters are best utilized for higher energy fields and put as 
opposite to the field as could be expected under the circumstances. 
 
2.10.1.7 Energy dependence 
Energy dependence is a term that is routinely utilized yet regularly 
ineffectively elucidated. It is a proportion of the detector response to an 
institutionalized response; for example, signal response per unit absorbed dosage 
in water or irradiation in air from Co-60 reference radiation. With regards to OSL, 
this signifies the quantity of electrons freed for a given radiation energy in contrast 
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with the reference (Izewska, 2007). Every meaning of energy dependence depends 
on various principal moulds in regards to the interactions inside the dosimeter and 
the presence of charged particles equilibrium (CPE). Energy dependence can be 
evaluated as the proportion of the dosimeter reading to the dosimetric amount, 
that is the reading shown, contrasted with the ideal reading (Podgorsak, 2005). A 
case of this is presented in Equation 2.19. The proportion is taken in contrast with 
the signal response per unit absorbed dose measurements in water (Podgorsak, 
2005). 
                (2.19) 
 
2.10.8 Tissue Equivalent 
The radiation equivalent of detector materials to water with a common 
approximation for different soft tissues in the body is called tissue equivalent. Tissue 
equivalent depends on the radiation equality of the detector materials to water, a 
typical estimate for an assortment of delicate tissues in the body. It relies upon the 
effective atomic number of the dosimeter and the nature of the radiation, and a 
tissue equivalent detector can eliminate the requirement for correction factors and 
decrease computations for a detector system (Baird and White, 1982 and Kron 1993). 
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2.10.9 Dose-rate dependence 
Integrating systems measure the unified signal response of a dosimetry 
system. For such systems the measured dosimetric quantity should be independent 
of the rate of that quantity (Fig. 2.11) 
 
Fig.2.11: Response characteristics of two dosimetery systems. Curve a first exhibit 
linearity with dose, then supralinear behaviour and finally saturation. Curve B first 
exhibits linearity and then saturation at high doses (reproduced from Izewska, 
2007) 
 
Ideally, the response of a dosimetry system M/Q at two different dose rates 
(dQ/dt) 1 and (dQ/dt) 2 should remain constant. In reality, the dose rate may influence 
the dosimeter readings and appropriate corrections are necessary; for example 
recombination corrections for ionization chambers in pulsed beams. 
 
2.11 Types of Radiation Dosimeters 
2.11.1 Thermoluminescence dosimeters (TLDs) 
A  process wherein an irradiated material absorbs energy, that is then 
produced as a photon in the visible region of the electromagnetic spectrum, is 
known as luminescence. Thermoluminescence is a type of luminescence wherein 
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heat is delivered to the material which leads to the emission of light intensity 
(Mckinlay, 1981). Thermoluminescence detectors (TLDs) have wide applications in 
radiotherapy and are the most commonly used dosimeter in small-fields dosimetry.  
TLDs have the advantage of measuring doses in elevated dose gradient areas, with 
extreme spatial resolution on the dose build-up region and beam penumbra (Kron 
et al., 1993).   TLDs have been used for measurements in small fields (Francescon et 
al., 1998) and can provide a good cross-reference for output factor measurements. 
TLDs dosimeters are crystals which are generally non-conducting – i.e. the 
conduction band in the band model of crystals is exposed to ionising radiation, with 
some of the electrons gaining sufficient energy to make it into the conduction band. 
TL materials contain a quantity of inadequacies in the lattice site that can set-up 
electrons after the conduction band at an energy state that is connecting the valence 
and conduction bands. One of the most widely used TL materials is lithium fluoride 
mixed with magnesium and titanium (LiF: Mg, Ti) to introduce impurity. The gap 
between the conduction and trap has energy of the order of a few electron volts, 
and the number of electrons trapped during this process depends on the intensity 
of the incident radiation. Typically approximately 1% of the electrons within the 
conduction band are trapped (Horowitz, 1984c). However, the probability that the 
electrons get sufficient energy to breakout back to the conduction band, from which 
they are able to fall back  to the lowest energy in the valence band, depends on the 
depth of these traps and the temperature.  
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Fig. 2.12: The Mechanism of Thermoluminescence dosimetry (a) illustrate process 
before irradiation (b) movement of electron from valence band to conduction band 
during irradiation (c) After irradiation of the material, TLD are being read using 
Automatic TLD reader (Adapted from Mckinlay, 1981. 
 
Positively charged holes created by the ionising radiation in the crystal 
structure behave in a similar way. Through rising temperatures, the probability 
increases that electrons can have sufficient energy to be raised to the conduction 
band and liberate energy in the form of light after they recombine with a positive 
hole within the valence band. As with diodes, impurities again play an important role. 
They create the centres where the transition of the electron from conduction to 
valence band resulting in light emission. The rate of light produced depends on the 
temperature and the number of electrons trapped, and therefore on the absorbed 
dose in the crystal. 
A TLD can be considered as an integrating detector in which the number of e-
 
and h, which are trapped, is the number of the e-/h pairs which are produced during 
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the exposure. Every trapped e-/h emits one photon. Consequently, the number of 
emitted photons is equal to the number of charge pairs, which are also proportional 
to the dose which is absorbed by the crystal (Knoll, 2000). 
The rate  charge carrier to  break out in step with unit time (p) is given by 
means of the Randall-Wilkins principle  as in equation (2.20). 
 
kTEeP /
1  

       (2.20) 
Where  
τ  = the mean half-life of a charge carrier in a trap  
α = frequency factor  
E = energy of the trap (eV)  
K = Boltzman’s constant = 8.62 x 10-5
 
eV/oK  
T = the Temperature (oK)  
By increasing the temperature, the escape rate is increased and the mean half-
life of e-/h is reduced. This rate, as it is increased, reaches a maximum at a specific 
temperature and then is rapidly reduced. However, as the intensity of the emitted 
light is proportional to this rate, there is creation of a peak in the graph of intensity 
versus temperature, called the glow peak, and the graph is called glow curve (Fig. 
2.13). Through increasing the temperature, the escape amount is expanded and the 
implied half –life of e-/h is decreased. This quantity reaches its peak at a selected 
temperature after which is quickly  decreased. Conversly, as the intensity of the 
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emitted light is proportional to this quantity, there is introduction of a peak inside the 
graph of signal intensity opposed to temperature, referred to as the glow peak, and 
the graph is termed the glow curve (Fig. 2.13). 
 
 
Fig. 2.13: Glow curve of TLD100 (A) – after pre-heating procedure (B) The half-
lives of each peak can also be seen, peak half-life are presented on top right in 
table. (Adapted from Mckinlay, 1982). 
 
Owing to the thermoluminescence impact, light is delivered and because it 
passes through optical channels, it enters the photomultiplier tube (PMT) through 
the light direction and is measured. The PMT comprises of a photocathode which 
changes the occurrence of light into current. The current is then intensified within 
the  PMT to provide a result that can effectively be measured (Knoll, 2000). The 
sensitivity of most photocathodes have a sensitive peak wavelength of about 400 
nm. It therefore,  significant to select a suitable TL material (phosphor) which can 
produce light within the blue area of the electromagnetic range.  As the output of 
the PMT is relative to the number of photons that are generated, it is added 
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accordingly to the dose that is absorbed when the output is combined. Rather than 
integration, counting of the pulse can occur with the output being converted over 
into pulses which are then counted. An excellent reader must have a big 
transmission of light and be able to measure exclusive TL materials (Dam and 
Morenello 2006). PMTs with a low response are normally used for the detection of 
low intensities of lighting from TL materials (HPA, 1984). The reader tool is linked up 
to a computer system and the measured outcomes can be either saved within the 
PC or printed out in hard copy (Dam and Morenello 2006). More details for the 
Harshaw (model 5500) reader used for this project and its specifications will be 
further highlighted in chapter three. 
 
2.11.2  Characteristics of thermoluminescence Materials 
There are more than 2000 TL materials readily obtainable, but the most 
effective eight are applicable for radiation dose measurement (Table 2.4). From 
these available materials, a low atomic number is recorded in four and are seen as 
near-tissue equivalent materials with signal responses corresponding to that of 
human tissue. These comprise of lithium fluoride (LiF), lithium borate (Li2B4O7), 
beryllium oxide (BeO) and magnesium borate (MgB2O2). They are most useful for 
medical applications and also utilized as radiation monitoring devices in industries. 
The later materials (CaF2, CaSO2, Al2O3 and Mg2SiO4) exhibit over-response signals 
compared to healthy tissue owing to the size of the  atomic number Z. They are very 
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sensitive in terms of signal response and can be quantified as not tissue equivalent 
materials (HPA, 1984).  
TL materials are not perfect for measuring dose, however. Numerous 
elements must be considered with a view to discovering the maximum suitable 
materials The stableness of the signal produced could be very essential, in addition 
to the availability. Also, of significance is a low fading rate ( <5% per month) in 
addition to easy glow curves with a plain anneal heating cycle. Whilst the sensitivity 
of a tissue-equivalent material is not always very high, it can be increased by 
including impurities referred to as activators. As the number of activators in the 
materials are added, extra traps are made and extra emission of light takes place 
during the thermoluminescence process. This improves the performance of the 
material. This automatically adds up to the efficiency of the materials. 
Further to true performance and excessive sensitivity, a low variant response 
signal of the background is needed for high accuracy, with the goal of measuring 
low dose thresholds with doses lower than 100 µGy. Similarly, an even energy signal 
response over a sizeable variety of energies is required (Mckinlay, 1981). Preferably, 
a contemporary dosimeter should have a linear response over a wide range of doses 
and its reaction must no longer be influenced by the dose rate. The variance in 
responses due to the exceptional angles of incident radiation to the dosimeter 
needs to be highlighted. The dosimeter should additionally be small in size to allow 
the dimension of each absolute doses and excessive spatial decision (IAEA, 2005). 
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Typically, LiF doped with magnesium and titanium is the most widely used 
material. TLD100 is LiF: Mg, Ti comprises of 92.5% 7Li and 7.5% 6Li. However, the TL 
material used in this project is  TLD100H (LiF: Mg, Cu, P). Additionally, available are 
the TLD600, containing more 6Li, and the TLD700, with effective 7Li. Their signal 
response to γ-rays is similar but they vary in their sensitivity to neutrons, as 6Li has 
a higher thermal neutron absorption coefficient. MgB6O7 has similar behavior to 
LiF with better sensitivity (more than 5 times higher compared to LiF). Its difficulty 
is that an extra annealing exposure to radiation is required to limit the fading, as it 
is extremely sensitive to light. Li2B4O7 has reduced amount of sensitivity compared 
with LiF (10% of LiF) and is absorbing. BeO is an additional tissue equivalent material 
related to LiF with comparable sensitivity; however, it is lethal and further sensitive 
to light (Savva, 2010).    
 
Table 2.4: TL properties of different materials: across the column is the 
sensitivity/unit mass, dose threshold in µGy, fading factor (5 losses at 20oC) and 
the ratio of energy response. (HPA, 1984) 
 
Material Sensitivity per 
unit mass 
Dose Threshold 
(µGy) 
Fading factor  
(5 loss at 20oC) 
Energy 
response ratio 
LiF – TLD100 1 50 ~5y-1 1.3 
BeO 0.2 – 1 <100 5(in 1 to 5 m) 0.9 – 1.0 
LiB4O7:Mn 
(TLD800) 
<0.1 500 ~5(in 3 m) 0.9 
LiB4O7:Mn 
(general) 
0.2 50 – 100 <5m-1 0.9 
MgB4O7:Dy 5 – 10 20 – 50 <5m-1 1.3 – 2.4 
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2.11.3  Calibration  
2.11.3.1 Batch Calibration - Element Correction Coefficient  
Despite the fact that dosimeters are exposed to a uniform dose under equal 
geometrical conditions, their sensitivity or efficiency differs. The TL efficiency may 
be expressed as the TL light that is produced in line with the unit of absorbed dose. 
The discrepancy within the sensitivity of a standard batch of TL dosimeters is 
required, however, to be decreased from between 10 to 15 % to 1 to 2 % when the 
dosimeters linear check is done.The Element Correction Coefficient (ECC) is a 
correction component which relates the TL efficiency of a selected dosimeter to the 
common TL performance or efficiency  (TLE) of the calibration dosimeters and is 
given in (2.21). 
 
jTLE
TLE
jEcc         (2.21) 
Where  
ECCj= the ECC of a dosimeter j  
𝑇𝐿𝐸̅̅ ̅̅ ̅ = The mean TLE of the Calibration dosimeters: and 
TLEj= the TLE of the dosimeter j from the Field dosimeters  
As a way to calculate the average TLE a small subset of all the dosimeters is 
utilized, referred to as calibration dosimeters (CD). The average value of all the CDs 
is in comparison with the efficiency of each dosimeters. This dosimeter is  referred 
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to as field dosimeters (FD). To calculate the ECC for each one in independently. The 
TLE is proportional to the TL response (TLR) of the dosimeter expressed in equation 
2.22: 
 
𝑇𝐿𝑅 = 𝐾. 𝑇𝐿𝐸      (2.22) 
 
where : 
K= constant: 
TLR= the amount which is measured and produced when dosimeter is irradiated  
 
 
Therefore, by reducing the error in the efficiency of the intensity, the 
differences in the signal response is equally reduced. At this point, the correction 
factor is then increased with the signal response of individual dosimeter and its 
efficiency turn out to be equal to the average of the entire dosimeters. This resulted 
in all the dosimeters having same efficiencies (Fig. 2.14). 
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Fig.2.14. ECC Factor showing the field card, calibaration cards and the 
RCF(Reproduced from Savva, 2010) 
 
The real amount measured by the reader is the signal intensity that is generated 
throughout the TL procedure. Consequently, the ECC can be expressed in equation 
(2.23)  
  
j
j
Q
Q
Ecc 
       (2.23)
 
where : 
Q = the arithmetic mean measured intensity of the calibration dosimeters;  
Qj
 
= dosimeter charge j  
 
By decreasing the difference in efficiency, the variation of the measured 
intensity is equally reduced. In an event of adding new dosimeters, ECCs are re-
assessed with the purpose of getting the same efficiency as the previous ones. For 
60 
 
this to be accomplished,  the calibration dosimeter sensitivity needs to be constant 
(Harshaw 5500 Manual, 2004). 
 
2.11.3.2 Reader calibration factor  
If a regular geometry, regular operational conditions and similar reaction of 
the TLDS are performed, the part of the entire device that is not steady after a 
considerable time is the reader. Therefore, a reader calibration factor (RCF) has to 
be utilized that is expressed mathematically in 2.24: 
L
Q
RCF         (2.24) 
Where  
Q  = measured intensity of a calibration set: and 
L= generic expression of radiation quantity (gU).  
The calibration dosimeters sets applied for the computation of  Q  are 
generated by the software. These are the dosimeters  with reduced  mean value of 
the intensity measured for creation of the ECCs. The dosimeters are compared to 1 
to 2 % of the arithmetic mean of the dosimeters considered for calibration.  
It is important to obtain a correlation between Gray ( absorbed dose) or 
Sievert (equivalent dose) and gU. The dose measured from a dosimeter j is given by: 
 
KRCF
ECCq
D
jj
j
.
.

      (2.25)
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Where  
qj= charge from reader field dosimeter j  
ECCj
 
and RCF already defined above 
K is expressed in 2.26.  
 
D
L
K         (2.26) 
These parameters K (Ug/Gy), L and D are defined. 
 
2.12 Alanine/EPR dosimeters  
Alanine, one of the amino acids, pressed into the form of rods or pellets with 
an inert binding substance, is usually used for high dose dosimetry. The dosimeter 
may be used at the level of approximately 10 Gy or greater with enough precision for 
radiotherapy dosimetry. The radiation interaction results in the formation of alanine 
radicals, the concentration of which can be measured using an electron paramagnetic 
resonance (EPR), additionally known as electron spin resonance (ESR), and 
spectrometer. The intensity is measured as the peak-to-peak of the dominant line in 
the spectrum. The readout is not-destructive. The dosimeter is near-tissue equivalent 
and requires no energy correction within the quality range of therapeutic beam. It 
shows small or no fading for a few months after exposure to radiation. The alanine 
signal response depends on few environmental conditions such as temperature and 
humidity. In 2005, Podgosark in his investigation asserts that alanine application for 
radiotherapy is in dosimetry comparisons amongst hospitals (podgorsak, 2005).  
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2.12.1 Principle of Alanine-EPR Dosimeter 
 
 
Fig. 2.15  Principle of alanine –EPR dosimeter during irradiation with 
ionising radiation that produces stable free radicals (reproduced from 
Morsy, 2012). 
 
 
 
 
 
 
Fig. 2.16: Distribution of amplitude signal intensity to absorbed dose. P-p 
height indicate the spectrum of signal (Morsy, 2012)   
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Fig. 2.17 :Alanine pellet dosimeters (2) alanine pellets place in  
carousels (Reproduced from Morsy, 2012)   
 
2.13 Ionization chambers 
Ionization chambers are the most extensively used class of dosimeter in 
radiotherapy centres. They offer repeatable measurements and an absorbed dose-
rate estimate traceable to primary national standards. They also have advantages 
over small-field dosimetry because of their accuracy and precision for beam 
calibration. Ionization chambers largely exhibit high sensitivity, instant readout and 
are practically energy, dose rate, and dose-rate non-dependent (Das, Ding and 
Ahnesjo 2008). On the other hand, standard ionization chambers are not appropriate 
for field dosimetery less than 4 cm2 for the reason that their active volume is large. It 
has been reported that micro-ionization chambers with active volumes varying from 
2 to 7 mm3 have been valuable for small field small field dosimetry. In 2000, De 
Wagter and De Neve investigated the result of a pin-point ion chamber for 
characterisation of small-field area utilized in IMRT.  
In brief, ionization chambers have a high sensitivity compared to other 
detectors; however, micro-ionization chambers have decreased sensitivity because 
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of their smaller active volumes. Leakage can therefore be considerable if not adjusted 
for, especially in small dose fraction of the beam (Leybovich, Sethi, and Dogan 2003). 
In addition, stem and cable irradiation can provide a spurious signal (Le Roy et al. 
2011; Lee et al.2002). An additional difficulty for micro-ionization chambers is that 
the displacement to determine the real point of measurement is not well known for 
small fields. Some micro-ionization chambers have central electrode made of  a 
metal, which may affect the response of the detector in a radiation field, especially 
when the photon spectra vary under narrow field conditions (Ma and Nahum 1993). 
Several publications have noted that the real point of measurement can depend on 
the detectors dimension as well as field size (Kawrakow 2006; Looe et al 2011). 
Accredited dosimetry calibration laboratories advise caution when attempting to use 
a micro ionization chamber as a primary calibration standard due to their lack of long-
term stability (Fig. 2.18). Comparison with other detectors and modelling the ion 
chamber response for different energy spectra using Monte Carlo modelling may be 
useful in this case (Ding et al 2006). 
 
2.13.1 Cylindrical and parallel plate ionization chambers. 
Parallel plate and cylindrical ionization chambers have cathodes of lower 
atomic quantity (Z) material, generally, the encasing air volume comprises aluminum 
and carbon as well as conductive plastic. The voltage linking the terminals is 
sufficiently extensive to accumulate the greater part of the signal response (charges) 
inside the sensitive volume, as a rule in the vicinity of 95 to 100 %, and sufficiently 
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little that the procedure is beneath the safe-limit for amplifying the region. The 
terminal electrode is protected by a guard to avoid current leakage and irradiation 
signals emerging through regions with a twisted field of electric.  
 
 
Fig2.18: Schematics for (a) cylindrical and (b) parallel plate ionization chambers.  
C552 is an air- Equivalent conductive plastic. Adapted from Erazo and 
Lallena (2013) and Mattson et al 1981) respectively. 
 
A complete chamber is protected with guard terminal increasing the volume 
of air, rather than remaining clear with or behind the semiconductor in detector 
casing. A typical example of a parallel plate and cylindrical IC arrangements are 
presented in Fig. 2.18. Different cases of the parallel-plate chamber incorporate the 
ionization chamber free in air and extrapolation-chamber (Khan et al 2010). The 
mean measurements stored, D, inside the quality of volume, V, is identified with the 
response charge received 
 Q, by 
𝑄 =  
𝑃𝑖𝑜𝑛𝑒𝜌𝑣𝐷
𝑊
            (2.27) 
where Pion is correction factor and  e = electron, ρ = density and W = energy 
created within the charge particle.  
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As electrons and particles flow toward the anode and cathode, separately, they stir 
up the reflected terminal charges. The measurement of activated charges dQ,  when 
a single electron or particle pass through  a separation dl inside electric field E can 
be can be calculate as in equation 2.28. 
1
2
𝑉0
2𝑑𝑄 = 𝑞𝐸𝑑𝑙       (2.28) 
 
Where: 
 V0 = potential energy 
Q = charge particles 
The stimulated and the reflected charges within the signal at the terminal are 
recognized with an electrometer. At some point electron and particles recombined 
and freed through the radiation field combine within the charge volume. It decreases 
the measure of the charge accumulated by the electrode, relying upon the electric 
field. This charges can be splited up and  recombination can be either intra-or 
between tracks. Expanding V0 diminishes the impact of recombination by expanding 
the force attracting the ion pairs separately at the generating point and expanding 
the flow of velocity. By changing V0 and fit charge collected with 1/V0 or 1/V2, either 
delivers a correlation close to linear fit.  The decision will rely upon the beam, voltage 
and gap size as well as fill gas structure (Fig. 2.19).  
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Fig.2.19: Behaviour of recombination effects in ion chambers. The 
correction factor for recombination can be determined by varying the 
voltage applied to the chamber and extrapolating the results to infinite 
voltage. During such measurements, the voltage is not increased beyond 
the nominal operating voltage. 
 
 
 
2.14 Diode Detectors 
Diodes are solid-state detectors that are a desirable option for small field 
dosimetry for their high sensitivity, lack of requirement for external voltage bias, 
simple instrumentation and inherently active small volumes (diameters of 0.6 – 
1.13mm, 0.01 – 0.06mm thickness), in addition to their superior response according 
to unit quantity due to both their density (one thousand instances that of air) and 
their lower w/e values (Dieterich and Sherouse 2011; Rikner and Grusell 1983). 
Various research groups have described the application of diodes for measurement 
of small field (Beddar et al 1994; Cheng et al. 2007; Gotoh et al., 1996; Mack et al. 
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2002; McKerracher and Thwaites 1999). There are two main types of diodes used 
for small-field dosimetry, unshielded and shielded. Diodes that are shielded contain 
a coating of a high Z material, usually tungsten, after the active volume to account 
for silicon over-response to low-energy photons (Cranmer-Sargison et al. 2012). The 
literature is inconclusive regarding the use of shielded diodes for small-field 
measurement. Several reports recommend that the added tungsten introduces a 
directional dependence and additional scatter (Mobit and Sandison 2002) for 
electron beams, while other publications conclude that shielded diodes require only 
minor corrections for small field measurement (Saini and Zhu 2004). 
Diodes have inherent characteristics that can limit their use in small-field 
measurements if not taken into account. Variations in measurement of up to 100% 
have been noted with accumulated dose (Eveling, Morgan, and Pitchford 1999). The 
composition of diodes is not water equivalent and can introduce a perturbation of 
the incident beam (Mobit Sandison 2002). Diodes also exhibit an energy 
dependence that must be addressed with energy-based correction factors (Eklund 
and Ahnesjo 2009; Francescon, Cora, and Cavedon 2008).  
 
2.14.1 Principle of operation of diode detector 
A silicon (si) diode dosimeter is a p, n junction diode. Tthe diodes are produced 
through taking n-kind or p-type silicon and counter-doping the shell to provide the 
alternative type material. These ones diodes are called n-si or p-si dosimeters, 
depending upon the base substance. Both class of diode are commercially to be 
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available, but  the p–si type is appropriate for radiotherapy dosimetry, seeing that it 
is much less influenced by radiation damage and has a smaller darkish current. 
Radiation produces electron–hollow (e–h) pairs inside the body of the 
dosimeter, which incorporates the depletion layer. The minority carriers produced 
within the dosimeter, inside the diffusion length, diffuse into the depleted area 
(Fig.2.20). They may be swept during the depletion area underneath the action of the 
charged fields due to the intrinsic potential. This will then generate current in the 
reverse path within the diode. Typically diodes continue to be generally used within 
the short circuit mode, on the grounds that this model exhibits a linear correlation 
between the measured rate and dose. They may be normally operated with no 
external bias to limit current leakage issues. One of the most vital qualities of diodes 
are their sensitivity and its magnitude. 
 
 
Fig. 2.20: A diode  with a p-n junction made by doping the semiconductor with 
donors and acceptors at adjacent junctions. n-type diodes have the high doping 
level of n-type semiconductors and the low doping level of p-type semiconductors 
(Adapted from Podgorsak, 2005) 
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Diodes are smaller in size than ordinary ionization chambers. They may be 
relative dosimeters and aren't suitable for beam calibration, considering their 
sensitivity modifications with regular use because of damage of healthy tissue by 
radiation. They may be specifically beneficial for measurement in phantoms, for 
instance in small field measurement utilized in stereotactic radiosurgery or excessive 
dose-gradient regions inclusive of the penumbra area. 
They are also, frequently applied for depth dose measurements of intensity 
doses in electron beams, simulataneously measuring the dose distribution (in 
assessment of the ionization measured by way of ionization chambers). To be used 
with beam scanning devices in water phantoms, they will be packaged in a water-
resistant encapsulation. The encapsulation also protects the delicate diode from 
physical harm. They are most appropriate for use in in-vivo dosimetry on patients, 
or for bladder or rectum dose measurements. 
Diodes for in vivo dosimetry are provided with construct-up encapsulation 
and for this reason must be appropriately chosen, relying on the kind and quality of 
the clinical beams. Diodes need to be calibrated whilst they are used for in vivo 
dosimetry, and numerous correction elements need to be carried out for dose 
calculation. The sensitivity of diodes relies upon on their radiation history, and as a 
result the calibration must be repeated periodically.  
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2.15 Film Dosimetry 
Radiographic and radiochromic films have remained extensively utilized for 
2-D dosimetry. Radiographic film inherently has outstanding spatial resolution and 
provides good report measurements in small field dosimetry (Paskalev et al. 2003; 
Zhu et al. 2000). The primary issue in radiographic fils is the development procedure. 
Many hospitals are running out of films and the processing machine is getting worn 
out. In 2007, Pai et el  asserted that consistent dosimetric film measurements 
require a special software to verify the program for checking the consistency of the 
processing machine. In opposite, radiochromic films are most valuable in 
radiotherapy especially for small field measurement due to the fact that they have 
excellent spatial resolution and are near-tissue equivalent as well as not requiring 
processing of the film. (Niroomand-Rad et al. 1998). Numerous authors have utilized 
films for measurement of a small field in radiation therapy and small-field dosimetry 
and report dose accuracy within 2 to 3 % difference (Devic et al. 2005; Mack et al. 
2003; McLaughlin et al. 1994; Pantelis et al., 2008). 
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2.16 NanoDot OSL dosimeter 
The optically-stimulated luminescence dosimeters (OSLD) are a plastic disk of 
aluminium oxide doped with carbon (Al2O3: C). Unlike TLDs, OSLDs contain highly 
sensitive detector material, providing a more solid, cost-effective dosimeter 
(Jursinic, 2010).  OSLDs require a small amount of optical light and relative sensitivity 
for stimulation and for detection of the recorded dose. Subsequently, the dose 
records are relatively constant inside the OSLD light-tight casing, and multiple 
readouts can be recovered from the same dose record to improve statistics. 
Depletion of OSLDs dose record at room temperature occurs only when the sensitive 
material is revealed to sunlight, allowing the user to either store or delete dose 
records (Lavoie 2009, Sinclair 2013). 
 
2.16.1  NanoDot OSL Operational Principle 
Nanodot OSL dosimeters, manufactured by Landauer, Inc., are used in this 
project. The Nanodot is a detector which allows for immediate dose assessment. 
They feature a 1 x 1 x 0.2 cm tissue-equivalent plastic casing surrounding a 4mm 
disk of  carbon-doped aluminium oxide (Al2O3:C), which comprises the OSL material 
sensitivity (Scarboro & Kry 2012) (Fig. 2.21). Aluminium oxide (Al2O3) is a crystalline 
structure that contains valence and conduction bands. Typically, carbon doping 
incorporates electron and hole traps into the forbidden band gap (Fig. 2.22). During 
irradiation, the valence band electrons are excited into the conduction band, 
creating holes of electron pairs. A portion of these pairs recombine, but some are 
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trapped by the energy levels in the band gap. The trapped charged density is directly 
relative to the absorbed dose exposed to the OSLD. This recorded dose can be read 
by exciting the OSL material (Al2O3: C) with a suitable optical wavelength of light, 
around 540 nm, from a light-emitting diode (LED). Upon stimulation, trapped 
electrons excite towaVrd the conduction band, and subsequently some de-excite to 
the valence band, generating the luminescence that is detected by the 
photomultiplier tube of an OSLD reader, such as Landauer’s MicroStarTM dosimetry 
system (Sinclair 2013, Yukihara & McKeever 2008).   
 
 
 
Fig.2.21: OSL Nanodot (Al2O3: C) dosimeter adapted from Landauer, Inc. 
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Fig.2.22: (a) The OSLD structure contains valence bands, conduction bands, and 
forbidden bands or band gaps, formed the Al2O3. Caron doping introduces 
electron/hole traps in the band gap. (b) During irradiation, electron/hole pairs are 
excited and captured in the traps. (c) During readout, an optical stimulus causes 
some trapped charges to de-excite and luminesce (Adapted from Rivera, 2012). 
 
Landauer, Inc. introduced a pulsed OSL technique to read doses typically 
encountered at diagnostic radiological energies (Yukihara & McKeever 2008). Pulsed 
OSL stimulates the OSLD with LED pulses and detects the luminescence in a 
repeating, alternating sequence. This permits the reader to adjust the inducement 
as weak or strong, depending on the amount of luminescence, and therefore 
absorbed dose, that is detected (Yahnke 2009). The difference in this process 
increases the series of doses that the reader can record. 
 
2.16.2  OSLD properties 
OSL dose records can be erased when the sensitive Al2O3:C material is 
exposed to light. Jursinic, in 2007 states that irradiation by a 150-Watt tungsten-
halogen lamp is an effective approach to deplete the OSLD dose record. The 
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reproducibility of results when an OSLD is reused as well as the linearity of dose 
response to the x-ray tube current time product (mAs) for diagnostic energy ranges 
and doses was further investigated by Lavoie in 2011. Various other properties of 
OSLDs for experimental use are documented (Yukihara & McKeever 2008, Jursinic 
2007, Lavoie 2011). 
 
2.17 Diamond Detectors 
 
A complementary semiconductor to the silicon diode is diamond (Krammer 
et al 1998). Diamond has a substantially higher band hole than silicon (in termsof 
electron volots, Diamond = 5.54 eV  while sililcon diode =  1.12 eV ), which suggests 
there are not very many free electron carriers delivered at room temperature, 
prompting a high resistivity and congruently low leakage currents. Table 2.5. 
 
 
Table 2.5 :A typical properties of diamond and silicon diode. (reproduced from 
Alberto, 2004) 
 Silicon Diamond 
Band gap [eV] 1.12 5.47 (5.54)† 
Resistivity [Ω cm] 2.3  × 105 >1011 
Energy to form e/h pair [eV] 3.6 13 
Electron mobility [cm2V−1 s−1] 1350 1800 
Hole mobility [cm2V−1 s−1] 480 1200 
 
 
 
Ther moderately excessive energy required to make an electron/gap shape 
in diamond compared with silicon is compensated for with the aid of the 
outstanding electron and hole mobilities, consistent low constant dielectric need be 
consistent with good radiation quality. The gap between electron/hole pairs drifted 
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away from the initial position is  collection distance. In diamond, this is normally 
lesser than the detector thickness; the collection separation is proven in equation 
2.29: 
𝑑𝑒 = 𝜇𝜏𝐸     (2.29) 
Where: 
µ = portability charge electrons 
τ  = arithmetic mean lifetime 
E = electric fields. 
Charge traps in diamond are occupied and then counteracted as a result of 
the underlying light, bringing about the collection of charge separation and quick 
escalation at low dosage, thereby achieving a level which can be reduced by half of 
the pre-illumination value. This state of immersion is termed the 'pumped state' and 
can remain steady so long as the detector remains at a temperature of 23oC (average 
room temperature) and the dim inside chemical vapor deposition (CVD) of a 
diamond. To maintain a strategic distance from the likelihood of genuine dosimetry 
mistakes emerging from the absence of balance, commerical distributors of 
diamond detectors used for radiotherapy suggest pre-measurement of detectors 
before its experimental usage. 
Another effect that must be considered is a diminishing signal response with 
increasing size dose rate, which emerges because of the short electron/hollow 
recombination time. However, if the detector is to be calibrated at one dosage and 
then used at any other, a correction factor shoud be applied.The dose in water is 
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represented by Dw. An alternative effect that need be considered is a diminishing 
signal intensity with expanding measurement of dose rate, that emerges due to the 
short electron/hole recombination time. However, the detector need to be 
calibrated for its dose linearity before its applied in radiation treatment. The 
equation relating detector reading to pulse per dose rate (estimated in water) Dw is 
presented in (2.30): 
 
𝑀 = 𝛼𝐷𝑤
∆       (2.30) 
where α = correction factor, Δ ~1.00. Considering this correction factor, 
diamond has been seen not to be energy dependence. 
Lansley et al in 2010 reported that the detector is capable of being produced 
using either natural or synthesized (CVD) precious stones (Lansley et al 2010). A 
drawback of natural diamond detectors is that cautious choice and particular 
classification of every diamond is needed to guarantee the appropriate properties 
of the material, which  greately increases the cost of the detector. However, the 
drawback of this detector is its small volume estimation (a few cubic mm), which 
yields astounding spatial resolution and no significant dependency for angular and 
energy as well as temperature. Additionaly diamond is semi-water equivalent 
considering its atomic number Z, consequently is especially interesting for 
estimations in radiation measurements especially where electrons at the center 
cannot be accepted; for example, in lesser fields. Diamond detectors have appeared 
to be impartial for photon beams ranging from 4 to 25 MV, and beams of electrons 
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between 5 to 20 MeV (Fidanzio et al 2000). 
 
2.18 Radiation Quantities and Unit 
2.18.1 Monitor units  
Monitor units (MU) indicate the measurement unit in evaluating the 
recommended dose in Gray (Gy) specified by a linac; measurement is done at the 
linac's MU chamber. A linac is adjusted for transmission of a specific emission of 
radiation measurement average over a specified MU (i.e 23). For instance, the 
Novalis machine is aligned to give 1 Gy for every 100 MU at 5cm reference depth. 
This  1 Gy for each 100 MU alignments is the normal change in accordance with the 
machine’s inner-directed electrometer circuit chamber (Podgorsak, 2005). 
Computation of MU is an essential component of the SRS treatment plan, wherein 
the dose recommended to be given to a patient is changed over different MU for 
each radiation field to be applied. It has been highlighted that Pencil Beam is the 
calculation employed to convert the measurement into MU by means of factor 
formalism as described in 2.31. The quantity of monitor units is individually 
computed for each and all radiation field of a specified treatment design, 
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
         (2.31) 
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The variables in equation (2.31) are well explained in Chapter I (Khan 2003). 
MU calculations are done physically for QA goals. The performance of manual 
measurements of the dose to verify the utilization of MU for each field of radiation 
treatment plan are carried out by a certified Medical Physicist. The recommended 
manual MUs calculations need to sync with the TPS’s MUs within 2% in every field of 
exposure. In spite of this, manual verification performs a separate check of the MUs 
to limit parallax (human mistakes) error during radiation treatment plan, and 
occasionally errors due to software in a TPS (Bellerive et al 1998). Owing to the tumor 
size in stereotactic radiotherapy treatment and the biological implication of the brain, 
routine planned QA is an essential subject in radiation treatment. Thus, an 
independent MU confirmation program is required to incorporate with the QA 
program. (Schell, 1995). 
 
2.18.2 RDF measurements  
The dose at a reference depth in water (RDF) for a specified field size 
(fs), divided by the dose at the parallel point and depth in water for 10 x 10 cm2 
standard fs is referred to as the total scatter correction factor,  RDF. RDF is field 
size dependent (Khan, 2010).  
𝑅𝐷𝐹 =  
𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑑𝑜𝑠𝑒 𝑖𝑛 𝑤𝑎𝑡𝑒𝑟 𝑓𝑜𝑟 𝑎 𝑔𝑖𝑣𝑒𝑛 𝑓𝑖𝑒𝑙𝑑
𝐷𝑜𝑠𝑒 𝑎𝑡 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑓𝑖𝑒𝑙𝑑
                 (2.32) 
Arithmetically,  
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   𝑅𝐷𝐹 =  𝐶𝑆𝐹 × 𝑃𝑆𝐹                         (2.32b) 
Along these lines, RDF comprises together PSF and CSF, and once isolated by 
CSF, produces the PSF. In 2005, Podgorsak asserted that RDFs are not insignificant 
factors in the calculations of the dose to be given, even though small. RDF is calculated 
and classified during TPS commissioning  ensure it is to appropriate for the intended 
dose during SRS treatment. A number of researchers show that RDFs are likewise 
measured for QA purposes (George et al, 2004 and Schell, 1995) and in exceptionally 
specific conditions, for examining an MU inconsistency.  
Furthermore, they suggest that the total scatter factors (TSF) are measured 
utilizing a similar linac's calibration settings, otherwise called reference fields. It also 
requires that dose is measured at the same depth with the same SSD where the 
standard output of the linac is measured. RDF is standardized for fs, for the most part, 
a jaw and m3 mMLC fs of 10 x 10 cm2, otherwise called reference field (Das et al 2008, 
McKerracher and Thwaites, 2007). RDF measurement at other than reference field is 
also referred to as a relative field. This quantity presents the median calibration field 
which is a device reference field for the detectors (Alfonso et al 2008). The 
experimental set-up of RDF measurements in reference conditions is presented in 
Fig.2.23.  
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Fig.2.23: Measurement set-up and reference conditions for RDF. 
reproduced from Khan, 2003. 
 
RDF is a correction factor among other correction factors selected  in 
measurement for the computation of MU dose. This is expressed arithmetically in 
equation (2.33) below. The precision of MU relies upon the exactness of the 
correction factors included. Another method for calculating RDF utilizes a halfway 
depth and measured PDD (field, depth) (Cheng et al 2003). The technique however 
maintains the acceptability of RDF meaning. In this approach, RDF is first measured 
at depth d in water for a specified fs A and computed as indicated in equation (2.32) 
applying the PDD measurements for fs of A and 10 x 10 cm2 :  
𝑅𝐷𝐹(𝐴,𝑑𝑚𝑎𝑥)=𝑅𝐷𝐹(𝐴,𝑑)×𝑃𝐷𝐷(10,𝑑)
𝑃𝐷𝐷(𝐴,𝑑)
       (2.33) 
Where RDF (A, dmax) = depth at Dmax, A, (Chang 2013).   
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2.19 Challenges to stereotactic and small-field dosimetry 
A small treatment field can be considered to be a field size of less than 4 cm 
x 4 cm (Taylor et al 2011). There are several dosimetric challenges encountered with 
small fields that are not seen in traditional radiation therapy treatment fields. These 
challenges include lateral charged particle disequilibrium (Seuntjens 2011, Attix 
1986), incomplete obstructing of the beam source providing rise to marked and 
corresponding penumbra (IPEM report 103), and the shortage of available small 
detectors that are of sizes smaller than the measurement field (Das et al 2008)  
 
2.19.1 Lateral Charged Particle Disequilibrium  
Electron equilibrium is a occurrence connected through the choice of 
secondary particles then consequently dependent on the beam energy and the 
configuration, particularly the density, of the medium (Aspradakis et al 2010). The 
condition for charged particle equilibrium is that for each particle that enters a 
volume V of mass M, an identical particle leaves the volume. When this requirement 
breaks down, electron disequilibrium occurs. At mega electron voltage (MeV) 
energies, the electrons produced have a considerable range that gets prolonged in 
a low density medium. At 6 MV, a minimum beam radius of 1.3 g/cm2 is needed to 
attain lateral electron equilibrium (Li et al 1995). 
As the field size gets smaller, a limit is reached where the distance from the 
point of interaction to the nearest field edge is reduced below the maximum range 
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of the secondary scattered electrons (Wuerfel 2013). As a result, lateral charged 
particle disequilibrium (LED) occurs. By small fs, this effect is sufficiently important 
to produce a lower total dose at the central axis of radiation beam and a spreading 
of the penumbra (Fig. 2.28). 
 
Fig. 2.24: Charged particle equilibrium exists at the point of measurement 
in (a) whereas nonequilibrium conditions are seen in (b) where the point 
of measurement is at the edge of a sharp dose gradient, affecting both the 
shape of the transverse beam profile and the absorbed dose (reproduced 
from Attix, 2007) 
 
 
Reference dose calibrations are performed according to IAEA report TRS 398 
or AAPM Task group 51 in a well-defined beam geometry, commonly using an 
ionization chamber as the reference chamber that is directly calibrated from a 
standards laboratory or cross-calibrated against one. Measurement of dose using 
ionization chambers depends on the models described in the Bragg-Gray cavity 
theory. The Bragg-Gray cavity is a very small detector which, when placed in a 
medium cannot perturb the charged particles fluence existing in the medium. If 
charged particle equilibrium (CPE) exists, the ionization created in the gas-filled 
cavity inside the medium is directly proportional to the absorbed energy in the 
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surrounding medium (Khan 2003). As the field size decreases, electron spectral  
variations occur relative to the reference field, causing an uncertainty of the dose in 
the small field compared to the calibration field, and the conditions for Bragg-Gray 
cavity theory break down (Das et al 2008). 
 
2.19.2  Partial Volume effects 
To measure the dose to a volume accurately, the dosimeter should be 
uniformly irradiated. The dose is measured by a dosimeter via the averaging of the 
measured charge above the absolute sensitive volume of the detector, where 
charge is directly proportional to the dose. Dosimetry in small fields and steep dose 
gradients can be affected for large sensitive volume in comparison to the size of the 
field. In small radiation measurement, the sensitive volume of the dosimeter can 
approach the field size. The sensitive volume may now measure over the flat field 
of the profile and include a portion of the penumbra. As the total measured dose is 
taken as the average dose above the sensitive area, the dose measured may have 
been inaccurate, therefore resulting in a signal that is reduced. For any field that has 
a sharp dose gradient (fall off), the effect of volume averaging causes a broadening 
of the dose profile.  
This brings about the importance of a dosimeter with a sensitive volume that 
is of a size that minimizes the volume-averaging effect, and as such, a dosimeter 
with high spatial resolution. When measuring the output factor for a specific field 
size, it is meaningful only if the dose is uniform over the dimensions of the detector. 
85 
 
If an unsuitably large dosimeter was to be utilized for output factor measurement 
forSRS/SRT fields, there is the potential to overdose the target and surrounding 
tissue due to underestimation of the output factor. This would also cause the input 
data into the TPS to be incorrect, resulting in inaccuracies of DVH as well as tumor 
control and normal tissue complication probabilities (TCP and NTCP respectively) 
(Taylor 2010). Consequently, this can have a significant effect on treatment 
outcome.  
In 2003, Laub and Wong reported on local inconsistencies of 10% between 
the measured dose and the calculated profiles within areas of sheer dose gradients, 
using film. The variation between the dose profiles was characterized as a function 
of the large volume of the original detector utilized in collecting beam-energy data 
during commissioning. With the application of a smaller detector, the difference in 
uncertainty was reduced to 2%. 
 
2.19.3 Source Occlusion 
The photon fluence generated by a linac is composed of primary and 
secondary components. The primary radiation beam originates directly from the 
target focal spot whereas the secondary radiation is produced from scattered 
photons. For the purpose of source occlusion, the scatter produced from the 
structures in the linac head is most important. Jaffray et al (1993) identified that 
secondary radiation can contribute up to 8%  scatter in a 6 MV beam. The target is 
not a point as such but is distributed over an area, and the exit profile size is 
controlled by the full width half maximum (FWHM) of the source profile. As the field 
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size decreases with decreasing collimator settings, the secondary radiation or 
scattered radiation is blocked by the collimators and its significance in the absorbed 
dose measurement is reduced. As the collimator size reduces and approaches the 
FWHM size of the source profile, the radiation beam originating directly from the 
target is also attenuated and blocked by the collimators. The output will then be 
lower in comparison to field sizes at which the whole source may be regarded from 
the detectors field of view (FOV). 
 
2.20  Detector Arrays overview 
MapCHECK® (Sun Nuclear Corp., Melbourne, FL) was the first commercial 2D- 
array detector using 445 n-type diodes. The diodes had a separation of 7.07 mm in 
the central 10 cm x 10 cm region and 14.14 mm in the external locales up to an area 
of 22 cm x 22 cm. This has since been superseded by the MapCHECK®2  which 
expanded the quantity of detectors to 1527 and kept up a uniform space of 7.07 
mm to have a dynamic range of 32 cm × 26 cm. Improvement of ionization chamber 
arrangements occurred not long after, with PTW (Freiburg, Germany) creating a 2D 
array which at first had 256 vented particle chambers with cross-sectional areas of 
8 x 8 mm2 which were dispersed 1.6 cm centre-to-focus. This was then improved to 
the more current model seven29 which has 729 chambers with cross-sections of 5 
x 5 mm2 and arrangement of 1 cm. The latter model is still being used; however, it 
has  been succeeded by the OCTAVIUS® 729 which features increased radiation 
shielding of the electronics. These devices were initially created to have the capacity 
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to measure per-beam fluence, and were intended to be set up typical to the 
direction of the beam. At the time that detector arrays were becoming financially 
accessible, electronic entrance imaging devices (which had begun being created in 
the mid-1980s) had developed, with linac vendors, by 2001, utilizing dynamic lattice 
detector arrays exhibiting amorphous silicon (aSi) photodiodes(Antonuk 2002). 
These devices were intended to evaluate the MV beam transmission through 
the patient to be utilized for imaging and patient setup checks. However, 
simultaneously with progressing imaging improvements of EPIDs, it was perceived 
that with fitting adjustment they could likewise be utilized for IMRT dosimetry 
verification (Van et al2004 and Van et al 2008). Using sub-millimeter evaluation, 
they began to be utilized routinely for IMRT fluence checks. Subsequently the 
utilization of detector arrays for these types of estimations became obsolete, and 
adjustments were made in equipment and programming to provide the capacity to 
estimate composite measurements distribution. For the PTW 2D-ARRAY 729, this 
included the improvement of the OCTAVIUS Phantom in order to decrease the 
precise directional dependence of the array’s non-ordinary beam frequencies (Van 
et al 2007). 
For additional detector array, cubic phantoms were utilized; however, as 
advancements in the calibration process were made, the user is was capable of 
performing estimations with their apparatus to describe the directional 
dependence, which can then be remedied out of the composite estimation. This 
88 
 
requires the utilization of an inclinometer to screen the gantry angle for each beam 
delivery (Boggula et al 2011).  
 
2.21. What is an ideal detector? 
 
 The factors which might influence an ideal detector array include:  
1. Accurate and precise 
2. Multiple readouts 
3. Water equivalent 
4. Directional independence 
5. Has no dependency in terms of dose-rate and energy. 
6. Has a high determination which is practically identical to or superior to 
resolution of grid spacing for dose computation in the treatment planning 
system. 
7. Be easy to calibrate 
8. Has the capacity to perform ongoing estimations so a determination of out-
of-resistance events can be made instantly.  
9. Resistant to thermal and humidity issues 
10. Requires minimal correction.  
11. Small in size 
12. Non-destructive readout and requires no cables for connection 
13. Reusability 
 
The main dosimeters that are currently accessible and possess the capacity to 
quantify a genuine 3D dosage distribution are polymer gel dosimeters. The benefit of 
these is that they are tissue-equivalent and can be formed into an anthropomorphic 
structure. After irradiations the dosimeter requires scanning using MRI, optical CT, or 
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X-ray CT and then processing of the measured signal. It has been evaluated that the 
whole procedure from construction to evaluation can take up to 45 hours, rendering 
this unacceptable for routine measurement (Baldock et al 2010)  
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Chapter 3 
 
Materials and Methods 
  
3.0 Introduction 
  In order for a detector to be considered thoroughly characterised a wide array 
of properties need to be understood. For this project, several detector stringent qualities will 
investigated through an individual experiment designed to isolate that particular proper. The 
basic setup of each experimental method will involve solid water phantom (RW3TM) and 
linear accelerator (CLinax 21Ix® ) in operation at Peter MacCallum Cancer Centre, Moorrabin 
Melbourne. The readout systems and procedures of alanine, nanoDot, TLD100H, 
microdiamond and diode will be highlighted as well as ArcCheck and film dosimetry. 
  
3.1 Materials 
 In this work, the materials and equipment used are presented in Table 3.1. The table 
indicates the equipment and characteristics of the materials considered in this study. 
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Table 3.1: Characteristics of equipment used 
 Alanine pellet dosimeters (3.00 ± 0.1 x 4.80±0.3)mm with 0.96/0.04 mass 
ratio alanine/binder respectively  
 Electron paramagnetic resonance (EPR) spectroscopy - Bruker Elexsys 
9.5MHz. 
 Silica gel – desiccant 
  Solid water phantom (RW3 slabs) 
 Calibrated ion chamber 
 LINAC (Clinax 21iX) 
 Desiccator  
 Storage box after irradiation 
 Thermometer 
 TL dosimeters (TLD100H) 
 Harshaw Bicron TLD reader (Model 5500Q) 
 Tweezers – assist with placement of dosimetric materials (chips, etc) 
 Micro-vacuum cleaners to aid in cleaning sample drawers 
 Dosimeter holding trays that provide excellent storage and staging for 
dosimetric materials. 
 Dosimeter carriers disks or carousel 
 Holders - Hubert phantom 
 Nitrogen pressure regulators and hoses to feed nitrogen gas into 
Harshaw5500 reader unit. 
 Application software for instrument and dosimeter calibration; computerized 
glow curve deconvolution; collecting, storing and manipulating data for dose 
algorithms; and quality assurance and diagnostic programs. 
 3-D printing machine 
 NanoDot dosimeters 
 Microstar reader 
 RW3 ( RW3 is a composition of Polystyrol and TiO2 and can only be purchased 
from PTW-Freiburg) 
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3.2 Experimental Method I – Alanine 
3.2.1 Alanine-EPR Measurement. 
The characteristics of alanine pellets dosimeters for stereotactic 
radiotherapy were studied with doses ranging from 5 to 50 Gy in 6 MV x-ray beam 
(Clinax 2Iix). The dosimeters used as part of the present investigation were made at 
the SynergyHealth®. The specifications of the alanine pellets dosimeters used in this 
study are listed in Table 3.2. All the alanine pellet tests were positioned each 
perpendicularly in a quartz tube with an internal diameter 10 mm and situated 
halfway in the round and hollow cavity. The dosimeters were inserted in a solid 
phantom (25 x 25 x 25 cm3) made of RW3 slabs phantom (water-equivalence). The 
alanine dosimeters were irradiated with a linear accelerator (Clinac 21iX) at 6 MV 
with 10 x 10 cm2 field size (fs) in the range of 5 to 50 Gy. The measurement was 
performed at maximum depth dose with sufficient backscatter material.  
An EPR spectrometer (Bruker EleXsys E500) of 9.5 MHz was employed to read 
the concentration of alanine signal intensity (Fig. 3.1). The irradiated alanine 
dosimeters were scanned two times for each dosimeter and the signal was divided 
by the mass of alanine dosimeter, which was assessed to be 67.5 ± 0.1 mg on the 
basis of EPR setting in Table 3.3. In order to reduce uncertainties each set of the 
alanine dosimeters were scanned at four orientations (0o, 90o, 180o, 360o), the 
average of which was recorded as average alanine EPR signal intensity.  
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Table 3.2: Characteristics of Alanine pellet dosimeter data sheet (SynergyHealth+) 
 
Characteristics Alanine pellet data sheet 
Batch Number: T030901 
Dosimeter Mass: 67.5±0.1mg 
Dosimeter Mass range: ±0.5mg; ±0.3mg 
Dosimeter diameter; 
height: 
4.80±0.1mm x 3.00±0.3 
Mass ratio alanine/binder: 0.96/0.04 
Typical dose range: 10Gy to 150kGy 
Linear dose response: Up to 3kGy 
Permissible temperature 
range: 
-100C up to 800C linear 
relationship 
Batch homogeneity of ESR 
signal: 
<±1%(k = 2), (mass 
corrected) 
Temperature coefficient: 0.001±0.0002K-1(-100C up 
to 800C) 
Fading: ~1% per year (25kGy) 
during dark and cool 
storage 
Accuracy of dose 
measurement: 
±3% 
*SH = Synergy Health  
 
 
Table 3.3: EPR (Bruker EleXsys E500) setting for alanine pellet readout  
 
Centre field 3400G 
Sweep width 150mT 
Sweep time 10.50s 
Micro-power 0.5024mW 
Field amplitude 4.0G(mT) 
Modulation frequency 100kHz 
Time constant 10.96ms 
Receiver gain 75dB 
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Fig. 3.1  : Bruker ElXsys E500 (9.5 MHz). The two red arrow showing the power 
console and the cavity where the alanine dosimeters are inserted after being 
placed in a quartz tube. 
 
 
Fig. 3.2: Irradiation set-up of alanine on 6 MV beam (ClinacTM 21ix). (b) Alanine 
dosimeters were placed on RW3TM water phantom and subsequently irradiated be 
delivering 10 Gy at 10 x 10 cm2 fs with SSD of 100 cm (b) alanine pellets aligned to 
the isocentre of the beam (b). 
 
95 
 
 
3.2.2 Alanine EPR linearity (Calibration Curve) 
Twenty alanine dosimeters with diameter of 3.0 x 4.8 mm were used for the 
calibration. Eleven dose levels were selected in the range 3 – 50 Gy.  The dosimeters 
were stored in a desiccator to avoid any relative humidity effect that may influence 
the EPR signal amplitude of the alanine detector (Viamonte et al 2008). At each dose 
level, two dosimeters were placed at 1.5 cm depth (dmax – 6 MV) in a solid water 
phantom centrally to the beam axis. The field size and the SSD were set at 10 x10 
cm2 and 100 cm respectively.  The pellets were exposed to different dose levels and 
a calibration curve was generated. The exposed alanine dosimeters were then 
transferred into a labelled pill box and kept for 24hrs to allow for the stable free 
radical process (Nagy and Desrosiers 1996; ISO/ASTM).  The concentrations of the 
free radicals were read using EPR spectrometer as discussed in section2.11. The 
acquisition parameters are presented in Table 3.2.  
 
3.2.3 Alanine angular dependence verification 
The directional dependence of alanine dosimeters during irradiation on a 6 MV 
x-ray beam was also investigated. The angular response of the alanine dosimeters 
was tested at three different gantry angles: 0°, 45° and 90°. Two dosimeters were 
irradiated in RW3TM slab phantom at each angles. All dosimeters were exposed to 10 
Gy at 600 MU/min for 6 MV X-rays. The exposed alanine dosimeters samples were 
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stored in air-tight container to avoid any known influences related to pre-irradiation, 
irradiation or post-irradiation prior to EPR readout. The irradiated alanine dosimeters 
were read using EPR EleXsys E500 based on the specification parameters in Table 3.3.  
Irradiated alanine dosimeters were positioned perpendicularly in a quartz tube (Fig. 
3.3) with 10mm of interior diameter and situated principally in the tube-shaped cavity 
for readout. The EPR signal amplitude was recorded after two consecutive scans, and 
then peak-to-peak of the highest spectrum was measured as the signal intensity with 
direct proportionality to the absorbed dose. 
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Fig.3.3: Alanine-EPR measurement (a) alanine pellet (3.0 x 4.8 mm), (b) 
EPR-quartz tube for positioning alanine onto the cavity (c) is the EleXsys 
E500 system with Xepr software display. (d) The peak-to-peak of the 
highest spectrum measured as the signal intensity directly proportional to 
the absorbed dose (Miyagawa and Gordy, 1960). 
 
 
 
3.2.4 Alanine Dose rate and Energy Dependence 
Dose rate and energy dependency measurement were also carried out prior 
to the usage of alanine detectors for pre-treatment QA of SABR plans. Twelve 
alanine dosimeters were irradiated at dose rates of 100 MU/min to 600 MU/min in 
steps of 100 MU/min. Two samples were placed simultaneously at the central point 
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of the beam axis in a solid water (RW3) slab phantomPTW. The dose delivered at each 
dose level was 10 Gy at 6 MV x-ray beam. A standard 10 x 10 cm2 field size was 
selected throughout the dose rate measurement, with 100 cm SSD. Alanine EPR was 
used to read the alanine signal intensity. After 24hrs of post-irradiation storage, the 
irradiated samples were scanned twice consecutively for each delivered dose level 
to analyse the signal amplitude of the alanine dosimeters. The irradiated samples 
were positioned perpendicularly in a quartz tube with 10mm of interior diameter 
and situated principally in the tube-shaped cavity for readout of the signal 
amplitude of the dosimeter. Similarly, the energy dependence of alanine signal was 
evaluated by delivering a dose of 10 Gy to two energies (6 MeV and 18 MeV) at 600 
MU/min. The selected alanine dosimeters samples were placed centrally at the 
beam axis on a solid water (RW3) slab phantomTM. Standard field size of 10 x 10 cm2 
was set with 100 cm SSD at 1.5 cm depth.  
 
 
3.2.5 SABR Measurement – Alanine 
In order to confirm the suitability of SH alanine-EPR and nanoDot dosimeters 
for stereotactic ablative radiotherapy (SABR) pre-treatment verification, a near-
water density material was designed. The designed material was made of 
Acrylonitrile Butadiene Styrene (ABS) with a density of 1.04 g/cm3 (approximately 
that of water) and was printed using a 3-D printing machine (Fig. 3.3). Alanine pellet 
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dosimeters were then inserted into the space provided (5mm) at the centre of a 
designed material and positioned in a Rod phantom (indigenous phantom) made out 
of Perspex that mimics the human body, to perform pre-treatment check 
measurement. Different treatment sites including spine, scapula and sternum were 
considered. The phantom was scanned on a Philips® Brilliance Big Bore computed 
tomography (CT) scanner, and the DICOM CT images were transferred to the 
EclipseTM TPS. Treatment plans were generated with 0 mm multileaf-collimator 
(MLC) margin to planning target volume (PTV). The approved treatment plans were 
then exported to an in-house designed rod phantom for dose verification. The dose 
was calculated at treatment-specific gantry angles. The rod phantom has provisions 
for inserting an EBT film and TLDs for measuring relative and absolute dosimetry 
respectively. Two separate inserts as described above were designed to 
accommodate alanine and nanoDot. Individually, the inserts were scanned and 
exported onto the rod phantom for SABR pre-treatment verification. 
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Fig. 3.4: Phantom Measurements. (1) Designed insert made of material related to water 
equivalent (2) Perspex to position the designed insert onto the  Rod Phantom for SABR 
treatment planning verification (3) and to the CT scan for treatment planning system 
(TPS), (4) and (5) are separate designed insert to accommodate alanine, TL and nanoDot 
dosimeters. 
 
 
3.3 Experimental Method II - NanoDot  
The nanoDot OSL Inlight dosimeters used in this work were from Landauer, 
Inc. Aluminium oxide doped with carbon forms a 5 mm dimensional disk of 
approximately 0.2mm thick, with a thin flexible strip of plastic made of polyester 
films on both sides of the disk used for covering, putting the total thickness close to 
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0.3mm (Dolo and Garcia 2006). The dosimeter material is contained in a plastic 
casing with a dimension of 10  x 10 mm with 2 mm thickness (Table 3.4). The 
sensitivity of the nanoDot OSL dosimeters was determined by exposing them as a 
group to 10 Gy in Clinac 21iX. The irradiated dosimeters were scanned and read in 
a single session, and the ratio of each dosimeters signal response to the mean of the 
set was applied as the sensitivity factor. 
 
 
Fig.3.5: NanoDots dosimeters from Landauer. The material is enclosed in a 
plastic casing of 1 x 1 x 0.2cm3 with a diameter of 5mm dosimeter disk and 
0.3mm thick. (a) Scan code (b) nanoDot material (Al2O3:C.) (b) dosimeter 
number. 
 
Table 3.4: nanoDot OSL dosimeters specifications (Landauer ®)  
  
Type of radiation x, gamma rays, beta 
Detector OSL (optically stimulated 
luminescence) 
Material Al2O3:C 
 Thickness:  2mm  
Case: 45 mm x 40 mm  
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3.3.1 Characterisation of nanoDot dosimeters for SABR treatment 
3.3.1.1 Verification of nanoDot linearity 
In total, twenty nanoDot dosimeters were utilized for dose linearity. Prior to 
calibration verification, the dosimeter was rescanned to check the background signal 
before exposure to radiation. Using nanoDotTM Landeur readout system (Fig.3.6), 
the dosimeters were placed in a holder for scanning, this process was repeated for 
two times and the average was obtained as the background signal. Two dosimeters 
each were placed in a solid water phantom (RW3) at dmax centrally to the beam axis 
(Fig. 3.2). The dose linearity was assessed by irradiating nanoDot dosimeters for a 
field size of 10 x 10 cm2 for 6 MV x-ray beam (ClinacTM 21ix). The irradiated nanoDot 
were kept void of ultravioilet light for 24hrs before being readout in a single section 
using LandaeurTM nanoDot readout system. The output of nanoDot dosimeter for 
various monitor unit (MUs) ranges from 5 to 4000 was determined. 
 
Fig.3.6: nanoDotTM OSLDs Landeur readout system 
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3.3.1.2 Verification of dose-rate dependence 
NanoDot system has been examined widely as it is the basis of a large number 
of the properties distinctive to OSLs. On account of dose-rate dependence this is the 
same; the period of the phosphorescence centres varies with the depth of the trap 
however will dependably be a finite value.  For Al2O3:C this is 35 ms and signal 
strength will just happen once the rate of signal trapping adjusts the rate of thermal 
discharge (Jursinic 2007). 
The measure of stimulation and excitation in OSLs can be interpreted by 
same mathematical equations to those utilized for TLDs. Utilizing arithmetical model 
and setting original conditions to characteristic value, Chen and Leung 2001 
suggested dose rate dependence for OSLs. This is in opposite to the numerical and 
observational data realised in 2010 by Pingqiang et al utilizing CaS:Ce,Sm, however 
utilizing an indistinguishable system from is being studied here, Viamonte et al 2008 
got an intensifying response with intensifying dose rate. This extensive variety of 
results proposes that OSL dose rate dependence changes on conditions, for 
example, the kind of OSL material being utilized. The experimental setup was similar 
to that used for dose rate dependence verification of alanine dosimeter (see 3.2.3). 
For uniformity with other experiments, the signal response of nanoDot dosimeter 
toward dose rate was investigated at 0.0o gantry angle for 6 MV beam (ClinacTM 
21ix). The nanoDot dosimeter was irradiated by giving 10 Gy for a 10 x 10 cm2 field 
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size and SSD of 100 cm, the doses were measured for different dose rates ranges 
from 100 to 600 MU/min.   
 
3.3.1.3 Verification of angular dependence of nanoDot dosimeter 
As discussed in 2.9.6 nanoDot OSLDs have been reported to change in 
response up to 4% in a 6 MV beam energy. The angular independent of nanoDot 
dosimeter was measured as a function of beam angles. The angles considered in this 
study were 0o, 30o, 45o, 90o for 6 MV x-rays beam. The SSD was set at 100 cm at 
dmax and 10 x 10 cm2 field size. The nanoDot dosimeters were placed at the central 
axis of the beam on a RW3 slab phantom. At each measurement 10 Gy was delivered 
for a repetitive-rate dose of 600 MU/min. 
 
3.3.1.4 Verification of Field size dependence (output factor) 
In 2000, Martens et al assert the signal response of a micro-ionization 
chamber for measurements of a smaller fs is of greater significance due to its 
capacity for IMRT plans verification. The performance of nanoDot dosimeters for 
radiation output was measured by delivering 10 Gy for different field size ranging 
from 2 x 2 cm2, 3 x 3 cm2, 5 x 5 cm2, 10 x 10 cm2, 12 x 12 x12 cm2, 15 x 15 cm2 20 x 
20 cm2, 25 x 25cm 2, 30 x 30 cm2, 35 x 35 cm2 and 40 x 40 cm2 for 6 MV x-rays 
beams, respectively. Identical procedure in 3.2.3 was applied to check the 
dependence of field size of the dosimeter to 6 MV beam at 100 cm SSD. 
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Fig. 3.7: Output factor of NanoDot dosimeters measurement  
set-up in 6MV x-ray beam (ClinacTM 21ix) at constant delivered     
dose of10Gy to different field size between 2 x 2 to 40 x 40 cm2. 
 
3.3.1.5 SABR pre-treatment verification of nanoDot dosimeter 
As discussed in 3.2.5 a separate insert was designed to fit in nanoDot 
dosimeter for SABR measurement. 
 
3.4 Experimental Method III - TLD 
In the TLD measurements, a total of 50 TLD-100H dosimeters and a Harshaw 
TLD readout system (Model 5500) was used (Fig. 3.8). To minimize potential 
variations between the TLD-100H dosimeters during the preparation stage, a group-
annealing-and-sorting (GAS) procedure was applied (Yu and Luxton, 1999). Before 
being exposed, all TLDs were group annealed for 10 min at 240oC and then cooled 
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down to room temperature. Table 3.5.  Indicate the summary of the readout 
parameters for TLD 100H. 
 
 
  
Fig.3.8: Harshaw TM TLD readout system (Model 5500). The redline showing the carousel 
where TL materials are positioned up to 50 slot for readout. 
 
3.4.1 TLD pre-reading procedures 
After the TLD reader was turned on, sufficient time (~ 30 mins) was allowed to 
warm it up (Fig. 3.8). To allow for sufficient cooling of the photomultiplier tube 
nitrogen valve (Fig.3.9) was opened 15 minutes prior to readout. Using regular 
tweezers, each TLD chip were placed into a TLD carousel, preserving the order of the 
TLDs were placed in a carousel slot 1, 2 … 50. To ascertain the carousel is placed on a 
clean work surface, as dirt and oils will prevent the carousel from spinning properly 
in the reader. The base of the carousel was covered with a clean tissue while handling 
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and loading to ensure the surface remains clean. Also, to ensure the fault light on the 
machine is not lit.  
 
 
Fig.3.9: (a) TLD reader Harshaw TM TLD readout system (Model 5500). (b) Nitrogen valve 
for pressure adjustment. 
 
3.4.2 Selection of Calibration Dosimeters 
In order to generate a set of calibration dosimeters, TLDs were first cleared 
(annealed) of any residual or spurious TL signal (Fig. 3.10) and then exposed to a 
known radiation and stored in a restrained UV environment at temperature less than 
30oC. These TLDs were then exposed at 50 cGy using Linac (Clinac TM 21ix) at Peter 
MacCallum Cancer Centre Moorabbin, Melbourne. The TLDs were stored for 1hr at 
a maximum temperature of 30oC to allow for fading out of the shallow TL peak. To 
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ensure identical fading time, the irradiation and read-out time remained constant. 
These TLDs were subsequently place in the carousel reader and read accordingly. 
The reader automatically read and designated the TLD chips as CDs that fall within a 
specified range around the normalized mean value of their response. Traditionally, 
this range is narrower than 0.9 to 1.1(±10%). 
 
 
Fig. 3.10: Annealing oven for removal of any residual and 
maintain thermal history of TL material. (Adapted from Peter Mac 
Cancer Centre East Melbourne, Australia) 
 
3.4.3 TLD Irradiation procedure 
 TLD chips were placed at the centre of a water (solid) phantom RW3 slab at the 
centre of x-ray beam with standard SSD for  10 x 10 cm2 fs and covered with 1.5cm 
build-up (bolus)  to compensate scatter photons (Fig3..).  50 cGy was delivered to fifty 
TLD chips at the same time to read for TL material sensitivity and its factor. This 
process was repeated three time to check for consistency in each TLD chip. 
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3.5 Experimental Method IV: Microdiamond Detector (PTW60019) 
Table 3.5: Specification of Microdiamond Detector 
 
Type of product Synthetic single crystal 
diamond detector 
Application dosimetry in radiotherapy beams 
Measuring quantity Absorbed dose water 
Reference radiation quality 60Co 
 
Normal sensitive volume 0.004mm3 
Design Waterproof, disk-shaped, sensitive volume 
perpendicular to detector axis 
Reference point On detector axis, 1 mm from detector tip, marked 
by ring 
Direction of incidence Axial 
Pre-irradiation dose  5 Gy 
Nominal response 1 nC/Gy 
Long-term stability ≤0.5% per year 
Dose stability <0.25%/kGy at 18 MV 
Temperature 
response 
≤0.08%/K 
Energy response ±13% (100 keV …60Co) 
Bias voltage 0 V 
Signal polarity Positive 
Directional response in water ≤1 % for tilting ≤ ± 40o 
Leakage current1 ≤ 20 fA 
Cable leakage ≤ 200 fC / (Gy.cm) 
Total window area density 101 mg/cm2 
Water-equivalent window 
thickness 
1.0 mm 
Sensitive volume Radius 1.1 mm, circular, thickness 1 µm 
Outer dimensions Diameter 7 mm, length 45.5 mm 
 
3.5.1 Experimental Measurement of PTW60019 
The microdiamond (PTW60019-Freiburg) (Fig.3.10) is a synthetic single-
crystal diamond detector (SCDD), in a Schottky diode configuration, operating with 
a 0 bias voltage. The application of  SCDDs has been explained (Francescon et al 
2008; Franceson et al 2011 and Francescon et al 2012) in concurrence with 
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conventional linac, with field sizes from 10 x 10 cm2  down to 1 × 1 cm2 as measured 
at standard SSD of 100cm.  In this work, we present the results using a dedicated 
stereotactic linear accelerator (ClinaxTM 21ix) with circular fields for fixed collimators 
ranging from 0.5 to 6 cm, at a nominal SDD of 80 cm, in a 6 MV unflattened photon 
beam. 
The microDiamond detector is waterproof, disk-shaped and sensitive volume 
perpendicular to detector axis design. PTW60019 has a thickness of 1-µm, 1.1-mm-
radius circular active layer, with a nominal sensitive volume of 0.004 mm3. Detailed 
speficiation of PTW60019 is presented in Table 3.5. 
 
3.5.2 Dose linearity of PTW60019 
The dose response linearity of microdiamond (PTW60019) was investigated 
by irradiating with doses from 5 to 5000 MU. The detector was inserted in a Rod 
Phantom (an indigenous phantom (35 x 20 cm2), Peter Mac Cancer Centre, 
Melbourne made out of Perspex that mimics the human body, to perform pre-
treatment check measurement. The MU linearity was check for two different energy 
6 MV and 18 MV at 10 x 10 cm2 field size for 100 cm SSD.  A linear model fit was 
applied to the data for each energy (6 MV and 18 MV) of the detector in order to 
obtain the signal response linearity. The signal strength and repeatability were 
verified for the detector in each energy by expressing the correlated experimental 
uncertainty for the above experiment in repeated measurements.   
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3.5.3 Dose-rate dependence of PTW60019 
To investigate the dose rate response dependence, the microdiamond 
detector was inserted in the solid water phantom (RW3PTW) at dmax for both 6 MV 
and 18 MV with SSD of 90. At each dose rate range 100 to 600 MU/min 100 MU was 
delivered at 10 x 10 cm2 field size. A trend line model fit was applied to the obtained 
data to check for dose rate dependence. 
 
3.5.4 Directional dependence of PTW60019 
The directional dependence of PTW60019 was verified by placing the detector 
at dmax in the solid water phantom (RW3). The detectors were irradiated by 3 x 3 cm2 
field size. The selection of the field size was to reduce the influence of the detector 
check to the main detector charge response (Ciancaglioni et al 2012). The detectors 
directional point was measured through an attachment, which enables the relative 
detectors rotation toward the central point of the beam in steps of 10o. The detector 
readings for each angular position were normalized against the reading at 0o (long 
axis of the detector parallel to the beam axis). The detector readings for each angular 
position have been normalized against each result at 0o (long axis of the detector 
parallel to the beam axis). 
 
3.5.5 Field Size dependence of PTW60019 (Output factor) 
The output factor was investigated  by means of microdiamond detector with 
6 MV and 18 MV beam, for the field size of 1 x 1 , 2 x 2, 3 x 3, 4 x 4, 5 x 5, 6 x 6, 8 x 8, 
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10 x 10, 12 x 12, 15 x 15, 20 x 20 cm2. The detector were positioned to dmax in solid 
water phantom (RW3) and 600 MU/min was delivered on each field size for different 
energy (6 MV and  18 MV). The output factors normalized at the 10 x 10 cm2 reference 
field  were obtained. 
 
3.6 ArcCheck Verification 
The ArcCHECKTM (Sun Nuclear with Model No: 1220, Melbourne), is a 3D 
beam measurement QA technique proposed for the verification of radiotherapy 
dose measurement distribution that are specified, as deﬁned by a planning system, 
and contrasted with the distribution of dose, as computed with TPS. The strucuture 
is of cylinder-shaped near water equivalent detector with a 3-D array leading to 
1386 diode detectors, positioned in a spiral pattern by spread out of 10 mm sensor. 
The focal point of the phantom (15 cm width) is made to house different fittings, for 
example, a cylinder, a dosimetric center through diode arrays or IC, an imaging QA 
core, a core with heterogeneous materials for dose investigations, etc. The 
ArcCHECK additionally includes two inclinometers to quantify the point of turn 
about the cylinder and to measure the gradient of the axis. A temperature sensor 
measures the ambient temperature of the detector region. Integration time for  
dose measurements each diode was 50 ms; there is no time breaking point or 
measurements constrain for an estimation (Fig.3.11). 
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Fig.3.11: ArcCheck phantom with phantom cavity plug and chamber insert. 
(Sun Nuclear, Melbourne) 
 
 
3.6.1 ArcCheck Linearity and dose repeatability 
The linearity of ArcCheck dose measurement was verified. Monitor units 
ranging from 5 MU to 10000 MU were delivered to ArcCheck for 6 MV and at 10 x 10 
cm2 field size setting. A range of monitor unit (MU) was chosen to cover the SABR 
plans. An average of two centre diodes was generated and the phantom response to 
100 MU was normalized to compute dose linearity. Comparable measurement was 
carried out with an ion chamber in water phantom for comparison. Repeatability of 
delivered dose is checked for ArcCheck. It is evaluated in terms of coefficient of 
variation. To check for its reproducibility, ten repeated dose measurements were 
experimented for 100 MU at 10 x 10 cm2 field size for 6 MV x-ray beam. For a 
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reference check, similar experiment was carried out with an ion chamber in water 
phantom for comparison.  
3.6.2 ArcCheck Field size and dose rate dependence 
ArcCHECK response for different ﬁeld sizes was assessed. Field sizes going from 
3 cm × 3 cm to 25 cm × 25 cm were presented for 100 MU. All readings of ArcCHECK 
phantom were standardized to 10 x 10 cm2 field size. Comparative measurement was 
done with an ion chamber in water phantom for assessment. The signal response of 
ArcCheck was estimated with various dose-rates going from 100 MU/min to 600 
MU/min. This estimation demonstrates the dose rate dependence of ArcCheck. 
Similar measurement was done with an ion chamber in water phantom for 
assessment. 
 
3.6.3 ArCheck directional dependence 
The directional dependence of ArcCheck was assessed for small angles along 
the longitudinal axis on two baseline measurement ion chamber (CC13 #5660) and 
diodes for two beam energies (65 MV F). A monitor unit of 200 MU was delivered 
to different gantry angles ranging from 0.0o to 6.4o. A standardized field size of 10 x 
10 cm2 setting was used throughout the measurement. ArcCheck was set to 0 
degree.  
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3.6.3.1 Small angles along Longitudinal Axis for 6 MV  
Baseline measurement (ion chamber): a calibrated CC13 #5660 (IBA 
Dosimetry, Germany) ion chamber with Dose 1 (IBS Dosimetry, Germany) 
electrometer was used for the pin-point measurements. Ion chamber was 
positioned at the isocentre with its axis coincide with the gantry rotational axis. The 
gantry angles was rotated from 0o degrees to the maximum angle of 6.4 degree at 
0.8o intervals. This setting corresponds to the greatest possible incidence angle for 
the diode at the edge of the field when the ArcCheck is centred to the isocenter. 
Similarly for diode measurement, ArcCheck was positioned on the treatment 
table with top central diodes at the isocentre height. The table top was rotated to 
90o. Two central diodes coincides with gantry rotational axis. Average readings of 
the two diodes were taken. Then the readings for the gantry angles symmetrical 
with respect to the vertical were averaged and normalised to the reading at 0o and 
compared with the ion chamber data. 
 
 
3.7 Statistical Treatment of Measurement 
Statistical treatment of data in radiotherapy dosimetry is often associated 
with the uncertainty, this can be expressed in terms of precision and accuracy. The 
exactness of dosimetry measurements determines the repeatability of the 
measurements under same conditions and can be evaluated from the results 
obtained from the repeated experiment. High exactness or precision is related with 
a small standard deviation of the distribution of the measurement data. The 
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exactness of dosimetry estimations is the nearness of their true value (expectation 
value) of the measured quantity. Therefore, results of measurements cannot be 
absolutely exact or accurate and the inaccuracy of a measurement result is 
characterized as ‘uncertainty’. Here, the uncertainty is defined as a constraint that 
defines the distribution of measured values of a quantity and this is evaluated by 
statistical methods (type A) or by other methods (type B), has no known sign and is 
usually assumed to be symmetrical. The error of measurement is the difference 
between the measured value of a quantity and the true value of that quantity 
(Podgorsak, 2005). Mathematically it can b expressed as in equation 3.1 
 
(3.1) 
The average uncertainty  of individual xi is  characterised in standard 
deviation x  
      (3.2) 
The standard deviation of the mean value is given by 
(3.3) 
 where N is the total number of points (data), N-1 is the degree of freedom, 
?̅? = the mean. 
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3.7.1 Statistical Limitations in Measurements 
Measurement limitation of the data presented in this work depends on the 
estimation of the ESR signal amplitude and a single combination of peak-to-peak, 
which is identified with the concentration of alanine yield following irradiation to 
set of doses delivered using 6 MV x-ray beams. This dose is depended on 
measurements using Ionisation chamber, which has  0.1% uncertainty. 
In terms of nanoDot, the readings and cumulative values were reported as 
the average. A scatter plot was generated using Excel Spreadsheet. Linear regression 
trend line and formula were derived to evaluate the correlation between the values. 
Using Origin®Pro 2018 software (RMIT IT services, Melbourne, Australia) was used 
to perform linear fitting and statistical analysis of the input data. Fitted curves plot 
and residual plots were obtained. 
 
Fig.3.12: The alanine-EPR spectrum illustrating the amplitude and single 
integration areas as utilize for the peak-to-peak analysis (Screen shopt during EPR 
scanning). 
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 Chapter 4 
 
Novel Spherical Phantom Design  
  
4.0 Introduction 
This chapter highlights the design of a spherical array detector phantom 
which give provision to insert diode detectors across the surface that will enable 
absolute and relative dose distribution measurement. Also, to develop software 
program using python to read RT dose and extract it to eclipse treatment planning. 
The python program written enable a conversion from 3D to 2D and also to display 
the dose distribution on a graphical user interface (GUI). 
 
4.1 Experimental Design and procedures (3-D Phantom Detector Design) 
A 3-D diode array phantom was designed using via punch card software. A 
total of 120 holes were provided across the surface of a 10cm diameter sphere that 
mimics the football (Fig. 4.1). At the centre of the sphere, an insert was provided to 
allow absolute dose measurement (i.e. IC). The distance between the spaces 
provided for diode insert was kept constant at 1cm apart for 15mm depth on each 
hole. In total 18 lines were drawn from the centre of the sphere, 9 hole-inserts in-
phase and  9 out of phase were created to ensure proper sparse distribution across 
the surface of the sphere. This was printed out using 3D printing machine with 
Acrylonitrile Butadiene Styrene (ABS) material. This material have density related to 
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water 1.04g/m3 (Fig. 4.1). To ensure free insert and wiring of the diode, the holes 
were further drilled and thoroughly cleaned using sand-paper. The created holes 
were marked and labelled accordingly. A radiation IN5626 switching power diode 
radiation was inserted wired and soldered accordingly (Fig.4.2). 
 
 
Fig.4.1: 3-D diode array phantom designed. The holes represent diode insert 
distributed across the surface of the sphere (using via punch card software) 
 
 
Fig.4.2: 3-D diode array phantom designed printout. The holes represent diode 
insert distributed across the surface of the sphere. (Using 3D-printing machine at 
Peter MacCallum Cancer Centre Moorabbin) 
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Fig.4.3 (i): 3-D diode array phantom designed with diodes being 
inserted and soldered to the wires that link to the PC card for 
measurement.  
 
 
 
Fig.4.3(ii): Phantom designed indicating the diode insert and wiring, 
cutting of the spikes. 
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4.2 Phantom continuity and resistance check 
The designed phantom in Fig.4.1 was tested for its continuity and resistance 
using a multimeter. This is to ensure that there is no damaged components or broken 
conductors in the circuit connection. Also, to ascertain the soldering is good and if 
the resistance is too high for low of current or if the connected radiation wire is 
broken between points. The end conductor of the diode (1N5626) was cut at the 
same level to of the sphere surface (Fig. 4.3), then immersed in a wax for several 
layers up to 1.5cm (Fig. 4.4). 
 
 
Fig. 4.4: Detector immersed in a wax ready for CT-scanning, after inserting 
and wiring of the diodes. 
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4.3 Ct Scan, Contouring and Treatment Planning 
The design detector was placed on CT scan couch (Brilliance Big Bore) 
[Fig.4.5) with a specific setting in Table 4.4, maximum kilo voltage (kV) setting of 140 
kV was determined, the spherical detector received a CT (computerized 
tomography) scan of the head and neck protocol with a total DLP (dose length 
product) was 807.2 mGy-cm for the scan, and the CTDI (computed tomography dose 
index) was 36.9 mGy for helical mode (Table 4.4). The scanned detector was then 
saved in a specific folder and exported to eclipse for external beam planning and 
contouring. Recent research has indicated the contouring errors as the principal 
issues in patient safety problems in radiation therapy. The reason is that they 
degrade dose distribution, dosimetry analyses, and contour-based visual guidance 
used in imaged guided procedures (Santanam et al 2013). Based on the established 
guidelines the designed detector was geometrically interpolated to proper 
consistency before treatment planning. 
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Fig.4.5: CT scan of the designed detector setup, Philip Bore at Peter mac, Moorabbin  
 
 
 
Table 4.1: CT Specific characterisation 
Type of 
scanner 
Aperture Focus 
isocentre 
distance(mm) 
Focus detector 
distance(mm) 
kV setting mA 
setting 
Power 
rating 
Philip bore (3rd 
Generation) 
85 645 1183 140 20 48 
 
Table 4.2: CT dose scan description 
Description Mode CTDI (mGy) DLP(mGy*cm) 
Surview Surview 0.0 0.00 
Surview Surview 0.0 0.00 
Skin 2/2 Helical 36.9 807.20 
 
 
 
 
124 
 
 
 
 
 
 
Fig. 4.6A: (A) Algorithm to extract dose from TPS, (B) Designed phantom 
verification interpolation (C) Contouring of the extracted algorithm (D) 
Phantom pre-treatment verification. 
 
4.4 Calibration of IN5626 switching power Diode 
In other to check for the suitability of diode application, calibration check was 
carried out to rationalised signal response of the integrated diode. The signal 
response was generated using signal generator and oscilloscope. The results of the 
diode performance is presented in Fig.4.11. 
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Fig. 4.7: Block diagram of diode signal response experiment 
4.5: Diode experiment with 3D designed phantom 
The designed diode detector was connected to the oscilloscope to check the 
signal response of the diode 6 MV energy. The positive end of the diode was 
connected to the designed detector and one of the channels (A7) using a coaxial 
connector, then the earth to the other side as indicated in Fig. 4.8B. The signal was 
checked using PC electrometer as indicated in Fig.4.9. 
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Fig. 4.8 1N5626 Diode Detector Signal response measurement set-up at 6 MV 
 
 
 
Fig. 4.9 (A) 1N5626 Detector Signal with PC electrometer, (B) 1N5626 Diode 
Detector Signal response @6MV. 
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Chapter 5 
 
Results and Analysis 
 
5.0 Introduction 
This chapter will detail more on the findings collected during this research.  
This chapter will incorporate all of the mechanism involved with the end result 
refers to the concept of verification of multiple detectors and its application in SABR 
pre-treatment verification. Establishing the results followed by the experimental 
procedure in chapter 3, the performance of the detectors considered in this study 
would be analyzed. 
 
5.1 Alanine-EPR Verification 
5.1.1 Alanine EPR linearity (Calibration Curve) 
The alanine EPR calibration curve (Fig 5.1) was obtained from a straight line 
plot using the least square approach. The results indicate that the dosimeter has a 
high degree of linearity within the range of 5 to 50 Gy for a 6 MV beam energy, by a 
linearity determination coefficient of R = 0.9976. The calibration indicates that the 
least square fit gives a good correlation between the delivered dose (MU) and 
ionization chamber response (Syamkumar et al 2012) for the least delivered dose. 
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Fig. 5.1: Dose response of Alanine-EPR for 6 MV beam at 10 x 10 cm2 with 2 % 
difference error bar. The trend line fit gives a function y = 0.2352x. R2 = 
 0.997±0.024 
 
5.1.2 Directional dependence of alanine dosimeter 
Fig. 5.2 shows the directional dependence of alanine dosimeters that was 
determined by irradiated gantry angles 0o C , 45o C, & 90o C. The graph shows no 
directional influence of the alanine sample dosimeters at the considered angles. The 
three angles considered have a value of 3.08 x 106, 3.04 x 106 and 3.07 x 106 with 
standard deviation of ± 0.02. The relative standard deviation of the selected angles 
was recorded at 0.68%.  
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Fig. 5.2: Directional dependence of Alanine-EPR at 00, 450 and 90o. The samples 
were placed in a solid water (RW3) slab phantom, 10 Gy was delivered using 6 MV 
x-ray beam at 10 x 10cm2 field size with SSD = 100 cm. The Stdev was recorded at 
±0.02 with a % RSD of ±0.6 %. 
 
 
5.1.3 Dose rate and energy dependence 
Fig. 5.3 shows the dose rate dependence curve from 100 to 600 MU/min for 
6 MV x-ray beams. The alanine dosimeters have a high dose rate-independent signal 
response for the dose ranging from 100 to 600 MU/min with a standard deviation 
of ± 0.4% for 6 MV and SSD of 100cm at 10 x 10 cm2 field size. This result was 
compared with ionisation chamber (0.6cc) in terms of energy dependence using the 
same methodology with 6 MV and 15 MV. The result indicates no significant 
difference between the energy considered. 
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Fig. 5.3: Dose-rate dependence of Alanine-EPR varied between Rep rate 
dose of 100MU/min to 600MU/mi with a relative standard deviation of 
±0.4 %.Two alanine samples were placed in a RW3 slab phantom, 10 Gy 
was delivered at 6 MV energy with 10 x 10 cm2 field size and standard 
source-to-surface distance (SSD) = 100 cm. 
 
5.1.4 Field size dependence of alanine (output factor) 
Fig. 5.4 presents the field size dependence of the output factor curve of the 
alanine-EPR dosimeter for a 6 MV x-ray beam. Using the same setup for ionization 
chamber in a phantom (water equivalent) the point dose verification were checked. 
The central axis of the phantom output factor measurements did not deviate when 
compared with an ion chamber for higher field sizes.   
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Fig. 5.4: Output factor of alanine-EPR (blue), at different collimator jaw-
shaped field sizes between 2 x 2 to 20 x 20 cm2 and 10Gy delivered dose. For 
F-test two sample for variance and Error b 
 
 
5.1.5 Measured Dose (MD) and Planned Dose (TPS) of alanine dosimeter 
Fig. 5.5. shows the measured and planned doses of the alanine dosimeter to 
different SABR treatment site including sternum, spine and scapula. Spine and 
scapula record similar average values of 17.77±2% and 17.825±1% for TPS 
respectively, while the alanine signal intensity of TPS and MD for spine was observed 
to be 19.827±2%. Based on the obtained results, the spine SABR treatment site has 
the highest value. 
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Fig: 5.5: Alanine EPR signal intensity for TPS and M/Dose at sternum 
(blue), spine (orange) and scapula (grey) SABR patient treatment sites 
with corresponding percentage difference. 
 
5.2 NanoDot Dosimeter Verification 
5.2.1 Calibration of nanoDot dosimeter 
A linear dose-response curve was generated, and the results indicate that the 
dosimeter has a good trend with a high degree of linearity within the range of 50 to 
4500 MU, with a linearity coefficient R2 = 0.9979 for 6 MV x-ray beam. The least 
square fit indicates that the linear relationship between MU and nanoDot signal 
response is good for the lowest delivered doses. 
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Fig. 5.6: Dose linearity of nanoDot dosimeters. Dose response for 6 MV beam at 
10 x 10 cm2 with monitor unit varying from 50 MU to 5000 MU.  
 
 
5.2.2. Verification of Dose rate dependence of nanoDot dosimeter 
 Fig. 5.7 shows the dose rate dependence of nanoDot. The dose rate 
dependence curve for nanoDot dosimeters from 100 – 600 MU for 6 MV x-ray beams 
illustrates a high dose rate response for the dose rates ranging from 100 to 500 
MU/min, having a standard deviation of 0.2% for 6 MV x-ray beams between the 
measured values. For suitability in this work, the results were compared with a 0.6 
cc ionization chamber with a maximum variation of 0.5% with 6 MV (Samkumar et 
al. 2012). The results of this experiment agree with those obtained by Viamonte et 
al. 2008 and Boyd 2016. The obtained results have an error of 2%. This suggests that 
in the case of Al2O3:C nanoDot® OSLDs, a dose rate dependence can be observed and 
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due to the statistical significance of this dependence, about 2%, the impact of dose 
rate will need to be considered to ensure accuracy and reliability in OSLD clinical 
use. The physical explanation behind this might be an expansion in the rate of 
electrons being trapped with a higher dose rate, which would give an expanded 
response signal at readout as a greater number of electrons would have turned out 
to be trapped. 
 
 
Fig. 5.7: Plot of nanoDot signal response as a function of dose rate for 6 MV beam 
at 10 x 10 cm2 with does rate ranges from 100 to 500 MU/min. Standard deviation 
of ±0.02 for a linear function of ‘y’. 
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5.2.3  Verification of Angular dependence of nanoDot dosimeter 
 
Fig. 5.8: Plot of nanoDot signal response directional response as a function of 
incidence angle for 6 MV beam at 10 x 10 cm2 with angle  ranges from 30o to 45o 
at 600 MU/min. Standard deviation of ± 0.02 for a linear function of ‘y’. 
 
 
Fig.5.8 shows the measured directional dependence of the nanoDot for 
repeated irradiation with a 6 MV x-ray beam. The results were normalised to the 
response at 0o, because 0o corresponds to the dosimeter disk being perpendicular to 
the central axis of the beam. The data indicate that at 30o and 45o, the response is 
reduced by approximately 2% for 6 MV. The results were consistent for the angles 
considered for 6 MV beam. The uncertainties here are represented by the error bars, 
which stand for the coefficient of variation of the nanoDot dosimeter readings. 
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Fig: 5.9: Dependence of field size (Output factor) of nanoDot dosimeter for 
6 MV x-ray beam. The field size ranges from 2 x 2 , 5 x 5, 10 x 10, 12 x 12, 
15 x 15, 20 x 20, 30 x 30, 35 x 35 and 40 x 40 cm2 , irradiated dose = 10 Gy, 
SSD = 100 cm. (A) Normalized output factor  for  field sizes 2 to 20 cm2 
gives a good trend curve; and (B) field sizes from 2 to 40 cm2, the curve 
dropped after 20 up to 35cm2 as indicated in the red circular line.  
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5.2.4 NanoDot dosimeter output factor 
Fig. 5.9 shows the field size dependence of nanoDot dosimeters. In order to 
establish the dependency of nanoDot with respect to field sizes, the dosimeters 
were exposed to radiation with field sizes ranges from 2 x 2 , 5 x 5, 10 x 10, 12 x 12, 
15 x 15, 20 x 20, 25 x 25, 30 x 30, 35 x 35 and 40 x 40 cm2 60 6 MV beam. A dose of 
600 MU/min was delivered by positioning the dosimeters at dmax with 100 cm SSD. 
The experimental uncertainty was calculated, and it was found to be 0.75% 
coefficient of variation. This shows the dependency of nanoDot reponse with the 
considered field sizes. It was also observed that beyond 20 x 20 cm2 the trend line 
curve drops to field size 35 cm and rose again (Fig. 5.9B). The results obtained 
suggest that nanoDot dosimeters be used instead of an ion chamber in the relative 
output factor measurement, as there is no significant change in trend line in the 
effect of OSL response compared to ion chamber (Viamonte et al 2008). Schembri 
and Heijmen reported in 2007 a maximum discrepancy of 2.5% with the usage of 
OSL; however, there is no such research for external electron beams. 
 
5.2.5 SABR pre-treatment verification of nanoDot 
Figure 5.10 shows the measured and planned dose of nanoDot response 
signal for a 6 MV beam. Three different treatment sites were considered: sternum, 
spine and scapula. The uncertainty was calculated and presented in form of 
percentage difference. The measured dose value ranged from 17.67 to 19.79 Gy 
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with a median value of 17.78 ± 0.16 respectively for sternum, spine and scapula, 
while TPS values ranged from 17.76 to 17.82 Gy with a median value of 17.79 ± 0.03 
Gy. As shown, (Fig. 5.10) the highest value for measured dose with nanoDot 
dosimeters was recorded at the spine, while the smallest value was recorded at the 
scapula. Similarly for TPS, the value at the scapula increases to 17.925 Gy while 
17.768 Gy was recorded at the sternum.  
 
Fig: 5.10: Plot of nanoDot dosimeter signal intensity as a function of TPS (blue) 
and M/Dose (red) for sternum, spine and scapula SABR patient treatment sites 
with corresponding percentage difference. Error bar shows the uncertainty for 
2% difference. 
 
5.3 Themoluminescence (TLD100H – 50 Set) 
5.3.1 Dose linearity of TLD100H 
TLD 100H calibration was obtained from a straight-line plot by the least square 
method. As shown in Fig. 5.11, the dose linearity of TLD 100H at 10 x 10 cm2 field size 
139 
 
for 50 cGy delivered at 100 cm SSD gives a high degree of linearity between 0 and 10 
Gy ranges for 6 MV beam. The regression R2 was recorded at 0.9998  1. The 
determination coefficient shows that TLD 100H gives a good signal response in terms 
of dose linearity. 
 
 
Fig. 5.11: Dose linearity of TLD100H. At 10 x 10 cm2, a dose of 50cGy 
was delivered for 100 cm SSD. 
 
 
5.3.1 Sensitivity factor  and repeatability of TLD100H 
Fig. 5.12 present the repeatiblity and sensitivity of TLD 100 H. The figure 
shows the consistency of three repeated experiment at different period of time. The 
sensivity factor of the repeated experiment was repeated in terms mean ±SD. The 
mean value for different experiment conducted was 882.970±0.009. The sensitivity 
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factor of the repeated experiment are presented in Fig. 5.13. The determination 
coefficient of R is unity. Also the percentage difference of the sensitivity factor was 
within the range of 2 to 7 compared to TLD sensitivity threshold of 10. 
 
Fig.5.12: Sensitivity factor of TLD100H. Three different repeated 
experiment at different time and date. 
 
 
 
Fig.5.13: Relative standard deviation (RSD) of TLD100H Sensitivity factor. 
That statistical fit of RSD is inserted in the diagram 
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5.3.2 SABR application of TLD100H 
 
Fig: 5.14: TLD TPS and M/Dose at sternum (blue), spine (orange) and 
scapula (green) SABR patient treatment site with corresponding percentage 
difference. 
 
 
5.4 PTW 60019 –microDiamond Detector 
5.4.1 Calibration of PTW60019 ( 6 MV and 18 MV) 
Fig. 5.15 presents the dose response of PTW 60019 as a function of different 
dose rates, ranging from 5 to 5000 MU for both energies, 6 and 18 MV. A dose of 
100 MU was delivered at 100 cm SSD. A plot of the dose response with respect to 
different MU was fit into a trend line with a linear equation of the form y = axb. The 
resulting power factor of ‘b’ values for each energy were 0.9987 ± 0.62 and 1.0000 
± 0.40. 
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Fig. 5.15: Plot of dose linearity of microdiamond detector as a function of different 
monitor unit ranges from 100 to 500 MU. A dose of 100 MU was delivered to the 
microdiamond that was placed at the central axis of the beam. 6 MV was delivered to 
the dosimeter at 10 x 10 cm2 square field size for 100 cm SSD. 
 
 
 
 
5.4.2 Dose-rate and energy dependence verification  
Fig. 5.16 shows the dose rate dependence of the  response of microDiamond. 
It can be seen that the detector exihibits a maximum dose rate dependence of less 
than 0.2%. This values lies within the experimental uncertainties in the range from 
100 to 600 MU/min. Similarly, the energy dependence of a microDiamond detector 
was verified for 6 MV beam energy prior to SABR application. The results are 
presented in Fig. 5.16. 
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Fig. 5.16: Plot of dose rate dependency as a function of microdiamond detector 
for 6 MV at 10 x 10 cm2 field size normalized to unity. SSD was set to 100 cm. A 
trend line was fit to linear equation with a regression, R2 = 0.0135. 
 
 
 
 
Fig. 5.17: Plot of energy dependence of microDiamond detector (PTW 60019) for 6 MV 
x-ray beam at 10 x0 cm2 at 100 cm SSD.The linear fit of both energies assessed are 
inserted above. 
 
144 
 
5.4.3 Field size dependence verification (output factor) 
Fig. 5.17 shows the field size dependency as a function of 100 MU of 6 MV 
and 18 MV x-ray beam. The field size ranged from 1 x 1 to 20 x 20 cm2, and was 
normalized to 10 x 10 cm2 field size measured at dmax. Both energies (6 and 18 MV) 
of the detector showed almost identical profile with good trend line fit.  
 
Fig. 5.18: Field size dependence of PTW60019 for 6 MV and 18 MV x-ray beam. 
The relative output factor normalized to 10 x 10 cm2, 100cm SSD. 
 
5.5 ArcCheck verification 
5.5.1 ArcCheck linearity and repeatability 
The signal response of the ArcCheck as a function of dose delivered indicates 
the linearity is better than 0.23% for monitor units greater than or equal to 5 MU. 
The gradient of the trend line along the ArcCheck phantom response curve is 0.999 
with R2 = 1.00 for 6 MV (Fig. 5.18). The response observed with an ion chamber (IC) 
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indicates linearity better than 0.23 % for monitor greater than or equal to 3 MU (Fig. 
5.18). With fewer monitor units, the linearity response is within 0.38 – 0.89 %. The 
slope of the trend line along the ion chamber response curve is 1.00. The R2 value 
for ArcCheck phantom is 0.66% coefficient of variation (COV) for 6 MV. A good trend 
line is evident for the dose per MU for 6 MV (Fig. 5.19). The reproducibility of 
ArcCheck obtained from repeated experiments with diodes for  6 MV  beam is  
presented in Fig. 5.20. 
 
 
 
Fig. 5.19: ArcCheck Linearity of 6 MV, 10x10cm2 for standard SSD 
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Fig.5.20: Archeck dose per MUfor 6 MV 
 
 
Fig. 5.21: ArcCheck 6 MV reproducibility, 200 MU 
5.5.2  Angular dependence of ArcCheck 
5.5.2.1 Baseline Measurement for ion chamber and diode  - 6 MV 
The directional response of ArcCheck was obtained by 10 x 10 cm2 field size 
data by employing an ion chamber (baseline measurement) which place in the 
highest path of deviating rays (approximately 10 mm infield of the geometrical field 
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point). The range of angles that these ion chambers make to the incident beam lies 
within the interval of 0.0 to 6.4o at 0.8o. This range covers the clinically-relevant 
angular incidence range of entrance for ion chambers which might be always 
perpendicular to the beam at 0 gantry and couch angles. 
Fig. 5.21 presents the directional independence of the ArcCheck baseline 
measurement using an ion chamber (CC13) rotating clockwise and counter-clockwise 
to a 6 MV beam. The TPS for the ArcCheck, normalized to a 10 x 10 cm2 field size at 
zero gantry angle, is presented in Fig. 5.22 The directional charge response of 
ArcCheck deriving from field size value through the utilization of the dose measured 
by diodes positioned on the treatment table with top central diodes at the isocenter. 
The table revolved at 90o to the angle that these diodes made, ranging from 0.0 to 
6.4o which covers the clinical sites of the incidence angle. The normalized 
measurement using an ion chamber and diode at G = 0 is shown in Fig.5.22. 
For 6 MV the directional independence field size of the ArcCheck diodes 
reduces with respect to the increase in beam divergence. Following the TPS, the 
measured doses of ArcCheck were decreased by 1 %, then 3% for 6 MV. For the 
directional incidence resulting from the 20 x 20 cm2 fs perpendicular to the direction 
of the beam, the measured response is approximately 2.5% greater than the TPS for 
6 MV. 
The three treatment sites for the evaluation of gamma criteria in this study 
were sternum, spine and scapula. The differences in gamma rates for ArcCheck and 
EBT3 films used for different gamma criteria for SABR treatment technique are shown 
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in Table 5.1. For gamma criteria of 3% and 3mm, the scapula and sternum pass rates 
for both ArcCheck and EBT3 film measurements were greater than 99%. The mean 
pass rates for spine were 95.13 ± 2.85% for ArcCheck and 99.62 ± 0.46% for EBT3 film. 
The distribution of passing rate at 3% and 1 mm, 2% and 2mm, 3% and 2mm, and 3% 
and 3 mm gamma criteria are demonstrated in Fig. 5.27. While the passing rates with 
different gamma criteria with their corresponding mean and standard deviation are 
presented in Table 5.3. 
   
 
Fig. 5.22: Angular dependence of ArcCheck baseline measurement using 
ionization chamber, 200 MU, 10 x 10 cm2. 
 
 
Fig. 5.23: Angular dependence of ArcCheck baseline measurement using 
ionization chamber, normalised to 0 degrees, 200 MU, 10 x 10 cm2. 
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Fig. 5.24: Angular dependence of ArcCheck reading from diode, 200 MU, 10 x 10 
cm2. 
 
 
Fig. 5.25: Angular dependence of ArcCheck for 6 MV percentage difference with 
respect to 0 degree reading from diode of  200 MU at 10 x 10 cm2. 
 
 
5.5.2.2 ArcCheck and Film dosimetry SABR Treatment verification 
    Table 5.1: ArcCheck  SABR treatment 
 
  Pass rate (%)   
Treatment Site 
3% 
1mm 2% 2mm 
3% 
2mm 
3% 
3mm 
 
Scapula 85 98 99 100  
Spine 56.2 85.6 86.6 94.2  
Sternum 89.9 95.3 97.4 99.2  
 Spine (L4u) 69.4 89.2 91.3 99  
Spine (T7u) 61.3 79.9 85.3 92.2  
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      Table 5.2: Radiochromic Film SABR treatment 
 
Treatment Site Pass rate (%)  
 
3% 
1mm 2% 2mm 
3% 
2mm 
3% 
3mm 
Scapula 98.15 99.66 99.99 100 
Spine 91.6 99.01 99.81 100 
Sternum - - - - 
Spine L4u 79.62 91.71 95.48 98.97 
Spine T7u 97.05 99.22 99.6 99.9 
 
 
 
 
Fig.5.26(a): Measurement vs TPS plan comparison using ArcCheck Spine SABR 
(3.00%, 3.00mm Gamma agreement of 99.3%) 
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Fig. 5.26(b): . Gafchromic EBT3 film analysis of Lung SABR (same patient as in 
ArcCheck) showing 3.00%, 3.0mm Gamma agreement of 99.98% 
 
 
Table 5.3 : ArcCheck passing rate with different gamma criteria in percentage 
and millimetres. 
3%,1 mm 2%,2 mm 3%,2 mm 3%,3 mm
Range 56.2% - 89.9% 79.9% - 98.0% 85.30% - 99.0% 92.2% - 100.0%
Mean ± Stdev 76.1%±9.7% 89.5%±5.3% 92.6%±4.2% 97.6%±2.4% 
Passing rates with different gamma criteria 
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Fig. 5.27: Distribution of passing rates of ArcCheck and EBT3 film for sternum, 
scapula an spine treatment sites. 
 
 
5.6. Alanine, nanoDot and TLD dosimeters relationship 
Fig. 5.1 and 5.6 shows the results of alanine and nanoDot calibration curve 
each measured in 6MV x-ray beams with the maximum delivered dose of 50Gy. It can 
be seen from the figures that alanine and nanoDot dosimeters have a good linearity 
153 
 
with R2 = 0.9976 and 0.9979 respectively. The output factors of alanine and nanoDot 
are shown in Fig. 5.32, while Fig. 5.33 shows the output factors of the dosimeters for 
F-test two sample for variance and error bars for the selected point with 2% value. 
The output factors of the two dosimeters considered are compared with NPL alanine 
and ionization chambers at different field sizes ranging from 2 x 2 cm2 to 20 x 20 cm2. 
The relative standard deviation of TLD sensitivity is R  0.5. The comparison of 
measured and planned doses of alanine and nanoDot dosimeters at different 
treatment sites are presented in Fig. 5.30. While Fig. 5.31. shows the percentage 
difference trend of the dosimeters and different treatment sites of patients for pre-
treatment verification for stereotactic ablative radiotherapy. 
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Fig. 5.28: Output factor of SH alanine (blue), NanoDot (purple), NPL alanine (green) and 
ionization chamber (red) at varied collimator jaw-shaped for field sizes between 2x2 to 
20x20cm2 and 10Gy delivered dose. 
 
 
 
Fig. 5.29: Output factor of SH alanine (blue), NanoDot (purple), NPL alanine (green)and 
ionization chamber (red) at varied collimator jaw-shaped for field sizes between 2x2 to 
20x20cm2 and 10Gy delivered dose. For F-test two sample for variance and error bars for 
the selected point with 2% value. 
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Fig: 5.30: Comparison of  TPS and M/Dose at sternum (blue), spine (red) and scapula 
(green) SABR patient treatment sites for alanine, NanoDots and TL dosimeters with 
corresponding percentage difference. 
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Fig: 5.31: Comparison of  percentage difference for Alanine, NanoDots and TL 
dosimeters at different SABR patient treatment sites. 
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5.7 Novel design results 
5.7.1 Diode (IN5626) linearity (Calibration Curve) 
Diode (IN5626) charge response was obtained obtained from a straight line 
plot through the least square system. The results indicate that the detector has a 
high degree of linearity in the variety of 50 to 2000 MU for a 6 MV beam energy, 
with a linearity determination coefficient of R =  0.9999 (Fig.5.32). The calibration 
indicates that the least square fit gives a good correlation between the delivered 
dose (MU) and ionization chamber response (Syamkumar et al 2012) for the 
delivered dose. 
Also, the response of the diode for different set of linac with integrated diode 
output for correspond rapt dose which checked to ascertain the applicability of the 
diode used in this study. This generates good linearity as shown Fig.5.33 
 
Fig. 5.32: Calibration curve of diode (IN5626) for 6 MV beam at 10 x 10 cm2 with 
2% relative standard deviation normalized to 100MU. 
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Fig. 5.33:  Diode (1N5626) Detector integrated diode output response at 6 MV x-ray 
beam. The legend represent different dose rate between 100 – 600 MU/min. 
 
5.7.2 Dose rate and energy dependence of diode (IN5626) 
The dose rate independence of IN5626 diode from 100 to 600 MU/min for 6 
MV beam energy are presented in Fig. 5.34. The detector response  charge indicate 
a considerable dose rate-independent charge response for the dose relating 100 to 
600 MU/min with a factor of 0.008 for 6 MV at SSD of 100 cm with 10 x 10 cm2 field 
size. Similarly, energy dependence characterisation for 6 MV and 18 MV was verified 
with a relative standard deviation (RSD) of ± 0.02%. This result was compared with 
ionisation chamber (0.6cc) in terms of energy dependence using the same 
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methodology with 6 MV and 15 MV. The result indicates no significant difference 
between the energy considered. 
 
 
Fig. 5.34: Dose-rate dependence of diode (IN5626) varied between Repetitive dose 
rates of 100MU/min to 600MU/mi with a relative standard deviation of ±0.4 %. The 
diode was placed in a RW3 slab phantom, 100MU was delivered at 6 MV energy 
with 10 x 10 cm2 field size and standard source-to-surface distance (SSD) = 100 cm. 
The uncertainty within the dose rate was 0.1 
 
 
5.7.3 Field size dependence of diode (IN5626) for 6 MV beam 
Fig. 5.35. Presents the field size independence of the output factor curve 
of the diode for a 6 MV beam energy. The factor doses were confirmed with an 
ionization chamber in a water phantom for the identical measurement setup. The 
measurement output factor for the central axis of the phantom confirmed no 
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deviation while as compared with an ion chamber for greater field sizes.
 
Fig. 5.35: Output factor of diode (IN5626)), at different collimator jaw-shaped field 
sizes between 2 x 2 to 40 x 40 cm2 and 10Gy delivered dose.  
 
 
5.7.4 Angular dependence of IN5626 
Fig.5.36 shows the measured directional dependence of IN5626 diode 
response at selected angle ranging from 0, 30, 45, 60, 90, 180 and 135o irradiation 
with a 6 MV x-ray beam. A linear fit was performed using a professional statistical 
analysis – Origin Pro Software. The results indicate that at 0.05 level, the slope is not 
significantly different from zero. The standard deviation of the diode charge 
response to the angles at the intercept recorded 0.489. 
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Fig. 5.36: Plot of diode response as a function of incidence angle for 6 MV beam 
at 10 x 10 cm2 with angle  ranges from 0o, 30o, 45o, 60o, 90o, 180o and 130o at 600 
MU/min. Standard deviation of ± 0.489  for statistical analysis of a linear fit using 
origin pro 2018.. 
 
 
5.8 Software development – Python Code 
 
Part of the objective of this thesis was to develop or write software code to 
read Dicom/rtdose files and display the dose distribution at the surface in 3-
Dimension. A python code has been written to extract the Dicom files. After 
treatment planning, the file was converted to Dicom files and exported to Python 
environment. Python 3.6.4 with Spyder 3 (Anaconda version) was used. Firstly, some 
python packages were imported to enable visualize medical images files, report and 
radiotherapy structures. Application packages such as Dicom, pydicom, numpy, 
matplotlib, etc were imported, prior to the setting of the isocentre point, the x, y 
and  z coordinate of the dose reference point was identified. A code was generated 
to display the slice thickness of the structure, the number of slices, the dose 
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matrices, dose reference point description and dose reference point coordinate. 
This was converted to an array and plotted in a 3D format using matplotlib as in Fig. 
5.37 a trend of the python code is presented in flow chart format (Fig.5.38).  
 
 
 
 
 
Fig. 5.37: A snap shot of 3D dose reference point distribution of the designed phantom 
using Matplotlib from Python (Spyder 3). 
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Fig.5.38: Flow chart for dose reference point cordinate distribution extracting from rtdose 
file using Python(Spyder3) code. The black arrow indicate the flow of the python script, 
green hexagonal shape represent the preparation connector and the red for end. 
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5.9 Summary 
 
The output factor measurement results of IN5626 diode detector for 6 MV 
beam energy are revealed in Fig.5.35. The output factor measured using PC 
electrometer yielded a high degree of calibration curve when compared with the 
output factor measured from Farmer ion chamber and CC13 chamber. Also, the field 
sizes at SSD of 100cm shows a good comparison when compared with CC13 and ion 
chamber with a RSD of ±0.02%. The relationship between measured and treatment 
planning system gives a suitable agreement of distribution of dose at the surface of 
the designed detector. Similarly, the directional dependence of the detector was 
verified. The results indicate that at 0.05 level that, the slope of the diode response 
for the considered incidents angle was non-significantly different from zero 
(Fig.5.36(b)). This result shows that IN5626 is suitable for the designed spherical 
phantom based on its characterization. Also, to check its suitability and application 
for SABR treatment quality assurance of the measured data were related with the 
dose distribution obtained from the treatment planning system.  
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Chapter 6 
 
Discussion 
 
6.1 Discussion 
SABR has become a traditional hypo-fractionated treatment technique in most 
radiotherapy centres due to its short overall treatment time.  One of the 
requirements of stereotactic radiotherapy is the pre-treatment QA, which ensures 
patient receives the planned dose with an acceptable dose accuracy. The detectors 
used for measurement must be thoroughly tested for different radiation beam 
conditions before being applied for pretreatment QA.  Dose linearity at high doses is 
one of the desirable characteristics of the detectors for SABR QA, as SABR is usually 
delivered as a single fraction. Furthermore, to perform as a radiation dosimeter, the 
desirable detector properties should be independent of dose rate, angular response 
and energy. In this study, we have confirmed the characteristics of alanine and 
nanoDot dosimeters and tested the efficiency of these detectors for pretreatment 
QA of SABR plans. To our knowledge, this is the first known study using alanine, 
nanoDot, TLD and microDiamond, as well as ArcCheck and film dosimetry, for pre-
treatment QA of SABR plans involving non-coplanar beams.  
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6.1.1 Alanine-EPR signal response  and nonoDot analysis 
Measurement of the alanine-EPR signal response by peak-to-peak spectrum 
was found to provide variable results owing to the errors associated with background 
deduction and for this reason, methods founded on the utilization of a more limited 
region of the spectrum were considered. The central peak-to-peak spectrum is well-
defined and the signal intensity of the signal was measured (Fig. 3.12), where the 
more limited range of field makes the measurement relatively increasing to normal 
distortion. The experiment in RW3 slab phantom showed a high degree of linearity 
for alanine pellet dosimeters within the range of 2 – 30 Gy. Linear curve fitting 
indicated a linearity coefficient of determination of R2  with a standard error of 0.9976 
± 0.011  for the 6 MV  x-ray beam. Based on the scatter graph of alanine linearity 
(calibration curve) the uncertainty is within 2% difference (i.e. 3.8 ± 2.1%). However 
<2 Gy yielded considerable background noise or distortion. Therefore, these 
measurements indicate the necessity to collect adequate measurements for doses 
less than 2 Gy. The differences in the calibration pellets of the alanine-EPR signal are 
clearly shown for the amplitude and peak-to-peak measurements (Fig.3.12). There 
have been concerns about this signal response that are the subject of continuing 
investigation between the read-out and time dependence. Based on Seco et al., 2014, 
alanine-samples were stored for at least 24 hours post-irradiation to allow signal 
stabilization of alanine radicals prior to EPR spectrum measurement. However, 
accessibility and location of the EPR spectrometer contributed to a variation of the 
measurements over 24 hour.  Although the results of the experiments described in 
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chapter 5 do not show a strong relationship between the measurement time and 
signal attenuation, this aspect of EPR measurements requires more systematic 
investigation. In this work careful control of storage conditions of alanine pellets was 
observed due to the possible effects of air moisture and water on the pellets, as 
indicated by Nagy, 2000. The least square fit illustrated a high correlation between 
the delivered dose considered in this work and doses to an ionization chamber by 
Syamkumar et al 2012.  
Similarly, nanoDot dosimeters demonstrated  good linearity within the range 
of 50 to 4500 MU with a linearity coefficient R2 = 0.9979. The uncertainty recorded in 
the nanoDot experiment was within 2% which is within the uncertainty limit as 
compared to the ionization chamber. This result enables the nanoDot application to 
SABR treatment patient-specific quality assurance. From the scatter plot of nanoDot 
linearity, the response tends to deviate for doses more than 20 Gy (Fig.5.6). This 
response has raised considerable concern. Recently, Ponmalar et al. 2017 conducted 
a comprehensive study of the linearity of OSL dosimeters for different energies (6, 
12, 16 and 20 MeV). Their results showed an R2 value ranging from 0.997 to 0.998 
within a dose range of 50 cGy to 1000 Gy. Their findings indicate a supra-linearity for 
doses greater than 10 Gy similar to that observed in the present study. Similarly, the 
supra-linearity of OSLDs to a therapeutic electron beam is comparable to that of 
external photon beams at doses greater than 2 Gy (Borgonove et al 2007).  
Alanine dosimeters (3.0 x 4.8 mm) and nanoDot dosimeters were 
characterized for linearity, angular response, and energy dependence. The results 
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indicate dose-rate independence of the alanine and nanoDot signal responses in the 
limited range of the investigated alanine dosimeters sample. The SH-alanine and 
nanoDot dosimeters showed no significant differences between 6, 15 and 18 MV X-
rays.  Alanine pellet dosimeters demonstrated a good dose response for a rapt dose 
rate range of 100 to 600 MU/min for 6 MV energy, with a relative standard deviation 
of ±0.4%. In experiments conducted at a similar dose-rate range (100 to 600 
MU/min), nanoDot dosimeters recorded a standard deviation of ± 0.19 at %RSD of 
2%. The degree of linearity of alanine and nanoDot signal responses demonstrated 
the potential use of these detectors for various high dose SABR fractionation plans.  
In addition to demonstrating this linear performance in a wide measurement range, 
alanine dosimeters have different qualities that make it an appropriate dosimetry 
material, such as a response free of dose rate dependence (Gall et al 1996), energy 
dependence (Scarboro et al 2015)  and directional dependence (Kerns et al 2011). 
In term of directional dependence verification, alanine in an RW3 slab 
phantom showed no directional dependence for the angles considered (0o, 45o, 90o). 
Similarly, there was no angular dependence observed in the nanoDot verification 
experiment at the same angles. In 2011, Kerns et al. comprehensively investigated 
the angular dependence of the nanoDot OSL dosimeter, which showed a response of 
4% at 6 MV and a lower response of up to 3 % at 18 MV when irradiated with a normal 
beam to the plane of the dosimeter. They concluded that there was no directional 
dependence, and also suggested that the nontrivial angular response is accounted 
for, especially for an external beam. 
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The output factors measured at different field sizes (2 x 2 cm2 to 40 x 40 cm2) 
clearly demonstrate the concurrence with standard output factors measured with 
ionization chambers. Both SH-alanine and nanoDot dosimeters provided comparable 
results, and these dosimeters can be utilized for absolute and comparative dose 
measurements in radiotherapy, especially in hypo-fractionated radiotherapy. 
Three different sites were considered for the validation of alanine and 
nanoDot dosimeters for SABR pre-treatment verification, including the spine, 
scapula, and sternum. The results demonstrated that the EPR and nanoDot 
dosimeters are comparable to the dose calculated by the Anisotropic Analytical 
Algorithm (AAA) in the Eclipse treatment planning system.  For all three sites 
(sternum, spine and scapula), the average measured and planned dose was recorded 
for alanine (18.29 ± 0.91 %  and 18.57 ± 1.12 %)  and nanoDot(18.29 ± 0.85 % and 
18.64 ± 1.31 %) respectively. This work indicates that for both alanine and nanoDot 
dosimeters, the measured  and planned dose agree well. Both alanine and nanoDot 
dosimeters considered in this work were within 2% to 3% percentage difference for 
the three different treatment sites considered 
 
6.1.2 PTW60019 – microDiamond charge response analysis 
Several investigations have been done on the performance of microDiamond 
(PTW 60019) detector, specifically for electron-beam and dosimetry of small field 
sizes(Mandapaka 2013), and more recently for dosimetry using proton beam(Yuichi 
et al 2015). However, the performance of PTW 60019 detectors for SABR pre-
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treatment verification has not been stated. In this project, the performance of 
commercially available PTW 60019 for SABR pre-treatment QA has been investigated. 
The linearity of PTW 60019  was found to be acceptable for both energies (6 MV and 
18 MV). This is similar to those of the parallel-plate ionization chamber (Yuichi et al 
2015. 
In 2013, Mandapaka et al. described the performance of synthetic single 
crystal diamond diode (SCDD) with small dose rate independence, their research 
shows a high rate of correlation between the measured dose using ionization 
chamber and the percentage depth dose (PDD) (Mandapaka et al 2013). For 
dosimetry with a photon beam, Chalkley et al. (2014), Marales et al. (2014) and Laub 
et al. (2014) also on the dosimetry performance of the PTW 60019 with the cyber 
knife, Novalis Trilogy Linac and  Elekta Synergy Linac respectively. In this project, the 
linearity with dose, dose-rate, and energy independence was investigated with 
respect to different field sizes. The microDiamond displayed excellent characteristics 
for electron beam energies of 6 MV and 18MV in terms of consistency of response to 
dose-rate, energy and field size (output factor). A diamond detector signal response 
was established with photon beams for different energy. The PTW60019 signal 
response did not change significantly (< 1%) and was in 2% measurement uncertainty; 
consequently, it can be supposed that the signal response of the detector displays no 
energy dependence with 6 and 18 MV beam energies (Fig. 5.16). Whilst this is 
expected owing to the near tissue equivalence of carbon, the interaction of the 
detector’s material and the PTW60019 – kind of casing might lead to a certain energy 
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dependence. The energy dependence was small, as expected when detecting on an 
in monoenergetic beams of an electron at mass stopping power ratio values for 
carbon and water. These reports correspond to SCDD models with a different type of 
detector casing (Venanzio et al, 2012). Finally, following the calibration curve of 
PTW60019 in this project, it was realized that the detector exhibits an uncertainty of 
±2.3%, this value is relatively small and is within the uncertainty of radiation 
dosimeters measurement. 
 
6.1.3 ArcCheck and Film Dosimetry analysis 
A part of this project was designed  to investigate the practicality of utilizing 
the ArcCheck as a substitute for ion chambers and film dosimetry. The correlations 
between these two methods were obtained utilizing the conventional gamma index 
techniques based on the concept of distance to agreement (DTA) and measurement 
contrasts inside predefined dosage limits. The DTA is the separation between a data 
point and the closest point in the calculated dose difference that displays the same 
dose (Low et al 1998). Several investigations have utilized a 3% dose difference and 3 
mm DTA with a 95% pass rate, or a 2% dose difference and 2 mm DTA with a 90% 
pass rate, to assess IMRT and VMAT treatment plans (Yan et al 2009 and Chaikh 
2016). In this thesis, both 3%/3 mm and 3%/2 mm were utilised for sternum, scapula 
and spine SABR individually to analyze the fluence estimated by film and ArcCheck. A 
tighter gamma standard for spine tumours is expected due to the area and the 
closeness of these tumors to the spinal cord. The gamma passing rate of 3%, 3 mm 
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for sternum and scapula indicated outstanding correlation between the two 
methods.  
The mean dosages for the ArcCheck and films for both sternum and scapula 
were also similar. The three treatment sites (sternum, scapula and spine) passed at 
2%, 2 mm and 3%, 2mm gamma criteria. However, spine SABR cases planned by IMRT 
may not be a good candidate for ArcCheck due to the sharp fall-off in doses at small 
field sizes. This has also been confirmed by Prabhakar et al. (2017). For these cases, 
our examination demonstrates that radiochromic films are required to characterise 
the dose spread. For spinal IMRT SABR pre-treatment verification, the spinal cord is 
near to the target volume, and as such, a slight miscalculation during setup of a few 
millimeters would compromise the dose to the target volume. Subsequently, it 
requires a high spatial resolution to identify the dose fall-off at the fringe of the target 
volume near the spinal cord with a set number of static IMRT fields. It is therefore 
suggested to utilize EBT3 films for all SABR spine treatment using IMRT.  
In 2013, investigations by Hussein et al. demonstrated a reduced relationship 
coefficient for the EBT2 films with the calculated gamma index utilizing five 
commercially available QA systems (PTW 2D-Array, Scandidos Delta4, SunNuclear AC, 
Varian EPID, and Gafchromic EBT2 film). This was found to be a result of noise 
artefacts caused by heterogeneity in the film. The gamma index examinations in EBT2 
films are also disturbed with fluctuationsinthe scanning methods. The main 
distinction between the EBT2 and the EBT3 films utilized as a part of this investigation 
is that the polyester layers of the EBT3 film are symmetrical, resulting in a decreased 
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level of artefacts (ISP 2009). The results for the ArcCheck method showed better 
agreement with the suggested gamma data for the gamma passing criteria of 3%/3 
mm and 3%/2 mm (Hussein et al 2013). The ArcCheck results obtained from sternum, 
scapula and spine SABR highlight the utility of ArcCheck as a substitution to film 
dosimetry. ArcCheck utilizes diodes with outstanding reproducibility and suitable 
directional dependence. It gives great sensitivity to the detection of small gantry 
rotation offset and scaling errors and also phantom set-up error (Letourneau et al 
2009). 
The presentation of SABR procedure in radiotherapy has increased the 
workload of clinical physicists. The standard ionization chamber and film dosimetry 
approach to QA includes a progression of techniques that incorporates output 
measurement, film dose linearity checks, film scanning, pre-and post-film 
processing, and specific programming to confirm estimated film and dose 
computation. Usually, the EBT3 films require much time during and after irradiation, 
and therefore, proper handling  and planning processes, including cutting to a 
particular size (for creation of the calibration curve and patient QA) and labelling the 
film must be considered before being exposed to ionizing radiation. The utilization 
of ArcCheck reduces physics QA time considerably. Moreover, it upgrades the 
physics throughput and limits human miscalculations in an occupied radiotherapy 
unit.  
Finally the diode (IN5626) detector was characterised to check its stringent 
quality including dose response, calibration, energy and directional dependence 
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before the application for SABR pre-treatment measurement. The results in Chapter 
four indicated no significant difference in terms of dose rate response and its 
calibration. A slight variation of directional dependence and energy was observed, 
which can be corrected as earlier highlighted in Jursinic 2007. In particular, the 
angular dependence of the diode (IN5626) at 0.05 level was found to be not 
significantly different from zero based on the statistical analysis of linear fitting of the 
diode response. A prototype spherical array detector has been designed and the diode 
characterised for linearity, field size, dose rate, energy and angular dependence. A GUI 
software package has been designed to read the Dicom RT plan and dose from the 
treatment planning system and the extracted dose correlated to the dose measured by 
the diodes. 
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Chapter 7 
 
Conclusions and Recommendations 
 
 
7.1    Conclusions 
In this study, an investigation on the characteristics of alanine nanoDot, TLD 
and micro diamond detectors as well as ArcCheck and film dosimetry and its 
application for SABR patient pre-treatment verification was performed. The results 
of the above detectors were within tolerance and no significance dose-rate, energy, 
and angular dependences on these output factors  were observed. The three 
treatment sites considered were consistent and showed good agreement between 
the calculated and measured dose, and proved to be a valuable dosimeter in SABR 
pre-treatment quality assurance.    A prototype spherical array detector was designed 
and the diode characterized by linearity, field size, dose rate, energy and angular 
dependence. A GUI software package was designed to read the Dicom RT plan and 
dose from the treatment planning system and the extracted dose correlated to the 
dose measured by the diodes. 
 
 
7.2    Recommendations for Future Study 
The proposed device is in its prototype stage and needs to be further 
evaluated for its angular dependence at different gantry angles. Due to limitations in 
funding we restricted our design to 1 cm between adjacent diodes. For SABR, very 
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high spatial resolution is required and hence our future experiements will be focussed 
on improving the spacing between adjacent diodes. The proposed prototype system 
exhibited leakage at high doses which may require further refinement to minimize.  
It is quite difficult to get a totally isotropic detector but materials with high atomic 
number should have to be limited to avoid dose artefacts testing of multiple cases 
and establishing of gamma criteria with software development needs be considered. 
 
7.3 Limitations of the thesis 
The detector designed during the course of this project is a prototype, 
therefore the precise position, spacing and actual depth of the diode are in need of 
optimisation. Resolution of diode distribution on the surface of the phantom need 
to be validated. It would be desirable to evaluate a greater number of diodes to 
obtain more accurate statistics. However, it is clear from the results, the diodes have 
less angular response to different gantry angles. It would have been advisable to 
quantify the degree of random variations in the result that might affect the 
conclusion reached. Nevertheless, the directional dependence was tested for the 
diodes considered in this study with different incident angles and the result was 
reproducible. 
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